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Burgeoning knowledge of the principles of tissue engineering has enabled periodontal 
surgeons to evolve from resective therapies to more regenerative approaches to treat the 
periodontal diseases that afflict a large portion of the population. These investigations 
describe the development of a novel 3D ex vivo scaffold derived from the Human 
Umbilical Vein (HUV) and its potential as an alternative surgical barrier material for the 
regeneration of periodontal tissues.  
Periodontal grafting materials should fulfill several requirements, of which the 
mechanical matching of the scaffold with the native residual tissue is crucial. However, 
little attention has been given to understanding the biomechanical behavior of oral soft 
tissues, and this represents an obstacle for the development of biomaterials that perform 
with appropriate biomechanical characteristics. With this as our motivation, an in vitro 
uniaxial mechanical analysis was performed on mammalian oral soft tissue to further our 
understanding of these complex tissues. Porcine oral soft tissues from both lingual and 
buccal sites were assessed to gain insight into human tissue performance and site-specific 
mechanical variation. Mechanical analysis was conducted on 3 different regions of the 
oral tissues – namely, the attached gingiva, alveolar mucosa, and buccal mucosa. Our 
hypothesis stated that a discrete quantitative mechanical analysis describing zonal 
behavior of each soft tissue region would correlate with published qualitative data. 
Results confirm the keratinized gingiva to have increased tensile strength and stiffness 
relative to non-keratinized mucosal regions, where densely arranged elastin fibers 
xx 
 
contribute to a tissue with increased viscoelastic properties. These investigations quantify 
the biomechanical properties of these oral soft tissues and show region-to-region 
variation that provides important insight into structure-function relationships necessary to 
support masticatory and other oral forces. 
Following the mechanical characterization of the porcine model system as reference, 
HUV were isolated from umbilical cords using a semi-automated machining technology, 
and decellularized using 1% sodium dodecyl sulphate (SDS). Uniaxial tensile testing, 
stress relaxation, and suture retention tests were performed on the acellular matrix to 
evaluate the HUV’s biomechanical properties and human gingival fibroblasts (hGF) were 
seeded to assess adhesion, metabolic function and proliferation on the scaffold. Results 
show the scaffolds biomechanical properties were dependent upon the complex 
composition of the ex vivo scaffold, with the composite nature of the ex vivo tissue 
contributing to the biomechanical variability. Cell proliferation and metabolic activity 
were shown to be dependent upon the surface characteristics; in this case the lumen and 
ablumenal surfaces of the vascular derived scaffolds. hGF migration into the scaffold was 
also influenced by the organization of extracellular matrix (ECM) components, where the 
lumenal surface inhibits cell migration, acting as a barrier, whilst the ablumenal surface 
promotes cellular invasion. The results have shown the HUV bioscaffold with its unique 
biochemical and biomechanical properties represents a promising naturally derived 
surgical barrier for periodontal tissue regeneration.   
In order to create functional HUV bioscaffolds for periodontal tissue engineering 
applications, in vitro 3D culture conditions were developed and optimized. The goal was 
xxi 
 
to assess the scaffolds’ capacity to initiate the regeneration processes while mimicking 
the physiological conditions. The HUV scaffold was decellularized according to our 
previously described protocol in order to remove the cellular components that may cause 
any immune reactions by the host. The human gingival fibroblast (hGF) cells were 
cultured on the HUV grafts under both static and dynamic conditions for 7 and 28 days. 
We hypothesized that the flow conditions would enhance the cellular biological activities 
towards the achievement of periodontal regeneration. The adherence, migration and 
proliferation capacities of hGFs were evaluated over time. Investigations were also 
conducted to test the gene expression profiles of the hGFs cultured on the HUV scaffold. 
The data presented in this study reveals the dynamic culture conditions enhance the 
attachment and migration of hGFs on the HUV tissue matrix, as visualized with 
histological and immunohistochemical analyses. The cellular metabolic activity, 













Periodontal disease not only threatens the oral health of a large segment of the adult 
population, but has also been implicated as a contributor to major systemic disorders, 
such as cardiovascular disease.
1, 2
 Several approaches have been adopted as treatment 
modalities among which periodontal tissue engineering has gained the most attention. 
One of the main goals of periodontal tissue engineering is to develop 3D tissue scaffolds 
that have the capacity to be remodeled and ultimately regenerate periodontal tissues that 
have been lost due to periodontal disease, specifically cementum, bone and periodontal 
ligament.  
Periodontal tissue engineering employs two main scaffolding techniques to regenerate 
lost support: periodontal grafting materials and physical barriers. Numerous studies have 
been conducted that demonstrate the advantages and drawbacks with the use of 
periodontal grafting materials.
3, 4
 However, the current golden standard for periodontal 
regeneration is the use of periodontal guided tissue regeneration (GTR) membranes, with 
or without the use of bone grafting materials.
5-7
 The main concept of GTR membranes is 
that a physical barrier or membrane is used as a protective shield to prevent epithelial 
downgrowth and thus provides a favorable environment for progenitor cells to repopulate 
the defect site and ultimately differentiate into cells that will regenerate the 
periodontium.
8-10
 Numerous cell types have been studied for their active roles in 
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periodontal GTR therapies, such as periodontal ligament cells and human gingival 




In the process of developing ideal GTR materials, however, further and detailed 
understanding of the complex interactions between the barrier and the native tissues is 
required. In order to achieve successful periodontal regeneration following reconstructive 
surgeries, biocompatibility, mechanical properties, and cell-selective characteristics of 
these barrier membranes must be optimally engineered in order to achieve predictable 
clinical outcomes.
13-15
 In addition, the biochemical composition, biological characteristics 
and mechanical properties of the periodontal replacement graft should match those of the 
neighboring native tissues. Nevertheless, particularly in medical applications, the 




In this study, we proposed that the human umbilical vein (HUV) would be a potential 
candidate periodontal GTR membrane. The HUV shows great resemblance to periodontal 
soft tissues, particularly, the gingival connective tissue.
20-28
 In addition to its selected 
biochemical characteristics, the HUV with its internal void spaces that are larger in the 
outermost region of the scaffold, i.e., the Wharton’s Jelly, may guide the fibroblasts to 
colonize the scaffold.
29
 The loose structure of Wharton’s Jelly surrounds the adventitial 
layer of the vein and comprises several growth factors.
30, 31
 Thus, the unique composition 
and architecture of the HUV membrane may offer advantages for facilitating periodontal 
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wound healing and tissue regeneration. However, a reference material still remains to 
serve as baseline for the mechanical requirements for the HUV.   
Therefore, one of the main focuses of this study was to characterize the biomechanics of 
a model oral soft tissue system. Porcine oral soft tissues were selected as the model 
system due to their resemblance in biochemical composition, histological organization 
and immunological properties to human tissues.
32, 33
 In this investigation, we 
hypothesized that the porcine model could provide a valuable indication of how human 
tissues would react under similar stresses. Our aim with this study was also to understand 
the mechanical property requirements for our novel periodontal scaffold, the HUV, in 
order to match the biomechanics of the human oral tissues in surgical practice. Ideally, 
the mechanical properties of the GTR barrier implant should match the properties of the 




In order to create periodontal scaffolding materials with defined properties, the design of 
an in vitro model system that simulates the physiological conditions is essential. 
However, the literature still lacks such in vitro systems that would allow studies of the 
interactions between periodontal GTR membranes and the surrounding tissue 
environment. Bioreactors are important devices to provide suitable environments for 
further improvement of the scaffolds while maintaining the mechanical and biochemical 
stimulation at the desired level.
35, 36
 Ideally, such a bioreactor system needs the harmonic 
functioning among the scaffold, cells and signaling factors, such as growth factors. 
Therefore, in this study, a model bioreactor system was designed to study the interactions 
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between hGFs seeded in the HUV-derived GTR membranes and the simulated 3D 
environment. In this study, it was hypothesized that the different conditions created 
within the bioreactor system would affect hGFs by altering their proliferative capacity 
and the synthesis of extracellular matrix (ECM) components.  
In the light of the above-mentioned aspects, the objectives of the present research project 
were threefold:  
1) To characterize the biomechanics of a model oral soft tissue system to better 
evaluate the mechanical response of the HUV-derived scaffold. 
2) To characterize a novel ex vivo human umbilical vein (HUV)-derived scaffold to 
test its potential as a guided tissue regeneration (GTR) membrane. The ability of 
the HUV bioscaffold to provide a favorable environment for early wound healing 
events was assessed by examining the proliferation, migration and viability of 
human gingival fibroblasts (hGFs). The sustainability of the HUV biomatrix 
under applied mechanical stresses was also determined.   
3) To examine the effects of the use of a novel pulsatile flow bioreactor system 
emulating the periodontal wound healing environment on hGF attachment, 
viability, proliferation and gene expression for various ECM proteins within the 
HUV scaffold. 
In order to better understand the pathogenesis and treatment of periodontal disease, 
Chapter 2 gives a detailed background on the tissues, molecules and cells of the 
periodontium, and the biological processes related to the disease. Chapter 3 focuses on 
the concept of periodontal tissue engineering and the current scaffolding technologies 
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that are used in periodontal treatment. Chapter 4 covers the biomechanical 
characterization of a model soft oral tissue system to give periodontal tissue engineers the 
opportunity to contrast/compare their novel ex vivo periodontal GTR barrier membranes 
with actual oral tissues. Chapter 5 describes the investigations undertaken to introduce, 
modify and characterize our novel ex vivo material- the HUV. Chapter 5 concludes with a 
comparison of the mechanical properties of our novel barrier membrane with those of the 
model oral soft tissue system. Chapter 6 introduces a novel bioreactor system and 
describes experiments conducted with our HUV scaffold within an environment 
simulating the conditions during periodontal wound healing. Chapter 7 addresses the 
hypotheses and goals of the project stated in this chapter and provides the main 
conclusions to the study. Finally, Chapter 8 includes an overall summary and suggests 















Periodontal disease is a mixed bacterial infection leading to a progressive destruction and 
loss of hard and soft connective tissue support of the teeth. Gingivitis and periodontitis 
are the two most common forms of periodontal disease. Formation of bacterial plaque 
biofilm on the tooth surface and calculus initiate the development of gingivitis. If 
treatment is not received, gingivitis could progress into the more serious later stage 
periodontitis. The indicator change for periodontitis is the downward migration of 
junctional epithelium and the consequent formation of a gingival pocket (Fig. 2.1). If 
untreated, periodontitis leads to periodontal disease and eventual loss of the teeth.    
 
 
Figure 2.1. Clinical pictures showing the healthy periodontal tissues (left), and the resolution of 
periodontitis with associated anatomical deficiencies (right).
37
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Several factors may cause the periodontal disease, such as the long-term colonization of 





 and Bacteroides forsythus
41, 42










2.2. STRUCTURE OF NORMAL PERIODONTAL TISSUES 
The periodontium consists of soft tissues (gingiva and periodontal ligament) and hard 
tissues (alveolar bone and cementum) and functions to support the teeth. Each of these 
periodontal components has distinct biochemical and biological composition and 
function. Fig. 2.2 illustrates the components of the periodontium – gingiva, cementum, 
periodontal ligament and alveolar bone.  
 
                          
 






2.2.1. Gingiva  
The gingiva serves as the protective outermost tissue layer for the periodontium. Like all 
other oral mucosal tissues, gingival is composed of an upper epithelial layer (gingival 
epithelium) and the underlying gingival connective tissue layer (lamina propria). The 
structural transition between the two layers is achieved through a boundary layer, called 
the basement membrane (See Fig. 2.3). However, a definite sub-mucosa is absent in 
gingiva. 
 
            
 









2.2.1.1. Gingival Epithelium  
Gingival epithelium is a stratified keratinizing layer acting as a protective barrier against 
the inflammatory and chemical substances, and mechanical stresses.
54
 Gingival 
epithelium, with a matrix devoid of fibrous proteins, consists primarily of squamous 
epithelial cells, and depending on the presence of cell nuclei, this layer could be either 
orthokeratinized or parakeratinized. Gingival-epithelial proteoglycans and 
glycosaminoglycans comprise the primary non-fibrous proteins of this layer.
55, 56
 Growth 




2.2.1.2. Gingival Connective Tissue (Lamina Propria) 
The connective tissue layer, i.e., the lamina propria, consists mainly of fibrous proteins 
embedded within a highly hydrated, non-fibrous tissue matrix composed primarily of 
hyaluronic acid, proteoglycans and glycoproteins.
58, 59
 The collagen fibers responsible for 
the bulk tissue tensile properties are relatively thicker and more densely packed in the 
attached gingiva.
60
 Healthy gingiva contains collagen type I (90%), collagen type III 
(8%), and collagen types IV, V, VI, and VIII (2%).
61
  
On the other hand, elastic fibers that provide tissue flexibility for extension and twisting 
motions are abundant in the alveolar mucosal connective tissue with a progressive 
reduction in density toward the gingival connective tissue.
22, 62, 63
  The network of elastic 
fibers is comprised of three different group of fibers, namely elastic, elaunin and oxytalan 
fibers. The elastic fiber is composed of two ultrastructurally distinct components – the 
10 
 
protein elastin and microfibrillar structures consisting of 10 to 12 nm in diameter.
64
 
Elastin constitutes 90% of the elastic fibers.
65
 The elaunin is on the other hand composed 
of less mature elastin protein.
66
 The oxytalan fibers are comprised of microfibrils lacking 
any elastic properties.
67, 68
 By contrast the buccal mucosal connective tissues possess a 
loose fiber network sparsely populated with collagenous fibers but relatively abundant in 
elastic fibers.
69
 In general, the epithelial layer undergoes higher deformation when 
subjected to load compared to the connective and submucosal tissue layers.
70
 
Proteoglycans, hyaluronic acid and glycoproteins, on the other hand, resist applied 
compressive and tensional forces while maintaining tissue hydration.
71
 The proteoglycans 
of the ECM of the gingiva are namely chondroitin sulfate (CS), dermatan sulfate (DS), 
and heparan sulfate (HS).
55, 72, 73
  
The most abundant cell type in the gingival connective tissue layer are fibroblasts, 
comprising 5.6% of the total gingival volume.
74
 Other cells residing in the lamina propria 
are mast cells, plasma cells, macrophages, and lymphocytes.
75
 Capillaries constitute the 
vascular components within the gingival connective tissue layer.  
2.2.2. Periodontal Ligament 
Connective tissue of periodontal ligament (PDL) consists of collagen fibers (94% type I 
collagen and 16-18% type III collagen) that traverse from alveolar bone to cementum, 
proteoglycans, glycoproteins and progenitor cells that can differentiate into periodontal 
ligament fibroblast cells, osteoblasts and cementoblasts.
76-78
 In addition, periodontal 





2.2.3. Alveolar Bone  
Hydroxyapatite (HA) is the main mineral that constitutes most part of the alveolar bone.
52
 
On the other hand, collagen type I is the principal collagen constituting the organic part 
of the alveolar bone.
80
 The vascular structure of alveolar bone comprises of cellular 
components such as osteoclasts, osteocytes and osteoblasts.
81
 The noncollagenous matrix 
proteins found in alveolar bone are the complex glycoconjugates, such as glycoproteins, 
glycosaminoglycans and proteoglycans. The major proteoglycan in alveolar bone tissue is 
chondroitin sulfate, with the other proteoglycans hyaluronate, dermatan sulfate and 
heparin sulfate.
82
       
2.2.4. Cementum 
Cementum is an avascular, hard connective tissue consisting of approximately 50% 
hydroxyapatite (HA) and 50% organic matrix, mainly calcified collagen fibers (types I 
and III) that are contiguous with the PDL.
37, 83
 Some of the important noncollagenous 
proteins present in cementum are laminin, fibronectin, osteonectin and 
glycosaminoglycans.
84-86
 Cementoblasts and fibroblasts constitute the cellular part of 
cementum.
87
 Cementum also comprises several growth factors, such as cementum-
derived growth factor and fibroblast growth factor.
79, 88
   
2.3. DISEASED PERIODONTAL TISSUES 
Numerous factors have been mentioned in Section 2.1 that cause inflammatory 
periodontal disease. These factors could function through different stimulus-responsive 
pathways. In the case of inflammation caused by bacterial pathogens, lipopolysaccharides 
12 
 
(LPS), major surface components of almost all gram-negative bacteria, stimulate 
epithelial cells and monocytes to produce cytokine proteins interleukin-1 (IL-1), tumor 
necrosis factors- (TNF-), and prostaglandin E2 (PGE2).
37
 The connective tissue 
fibroblasts interacting with LPS synthesize PGE2 and interleukin-1 (IL-6).  PGE2 inhibits 
fibroblast proliferation and collagen synthesis, and triggers bone resorption with IL-6.
89
 
The synergistic action of cytokines IL-1 and TNF- induce the periodontal tissue 
destruction through the synthesis of matrix metalloproteinase (MMP) enzyme.
90
 Among 




Fig. 2.4 illustrates the possible mechanism in the progression towards the periodontal 








          
 


















Qualitative and quantitative changes occur in the periodontal connective tissues, 
especially in the gingiva, with the development of inflammatory periodontal diseases. 
Barnett et al. (1989), observed temperature pattern changes in inflamed gingival tissues 
and hypothesized that might be due to a result of variation in gingival microcirculation.
92
 
The gingival collagen becomes more soluble with disease, and relative ratios of collagen 
types start to change.
93
 During the early phases of wound healing, the predominant 
collagen type is collagen type III, and is type I collagen when the healing is complete.
94
 
The total collagen content of gingiva has also been reported to decrease with the 
progression of the disease.
95, 96
 Similarly, the proteoglycan types and their distribution 
also showed variation in gingival connective tissues for the diseased subjects.
97, 98
 In 
addition, degradation of some gingival connective tissue proteoglycans and hyaluronic 
acid also occur during inflammation.
99
                                                                                                                                                                                              
2.4. PERIODONTAL WOUND HEALING PROCESSES 
The healing cascade of periodontal wounds due to periodontal disease, like most of the 
connective tissues, occurs in three stages: inflammatory phase, granulation tissue 
formation phase and the matrix remodeling phase. 
During the inflammatory phase, a blood clot which consists primarily of cross-linked 
fibrin and plasma fibronectin forms on the wound site.
100
 The inflammatory cells start to 
migrate toward the wound site through this fibrin matrix. The blood clot also provides the 
suitable environment for the migration, proliferation and differentiation of the progenitor 
cells taking a role in the tissue repair.  The cell migration process is mitigated by a series 
of events, mainly called chemotaxis. Chemotaxis is a chemical gradient-mediated 
14 
 
mechanism that attracts the healing accelerator cells to the wound site.
101
 
Chemoattractants and growth factors, with their specific interactions with cell surface 




The chemotactic secretory products, together with the inflammatory cells, fibroblasts and 
neovascular endothelium form a granulation tissue. As the healing progresses, 
granulation tissue develops further until the replacement tissue fully fills the wound 
space.  
The granulation tissue formation is then followed by the matrix remodeling phase, in 
which the ingrowth of cells and neovascularization of the granulation tissue changes into 
a tissue matrix that is subject to continuous remodeling. During matrix remodeling, 
synthesis of ECM components occurs in concert with the degradation of the tissue matrix. 
Connective tissue fibroblasts and growth factors are primary factors in matrix synthesis. 
On the other hand, degradation of the matrix can progress through different routes, such 
as activation of the matrix metalloproteinases (MMPs) (i.e. matrix degrading enzymes), 
release of reactive oxygen species (ROS) such as superoxide radical and the hydroxyl 
radical, and phagocytosis of matrix components, mainly collagen by the phagocytic cells, 
especially neutrophils and macrophages.
103-106
 
Periodontal wound healing is a complex biological process involving the interactions 
between different cell types (keratinocytes, fibroblasts, endothelial cells, macrophages 
and platelets),
107
  a signaling network of several growth factors, proteoglycans, cytokines 
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and chemokines, and the extracellular matrix (ECM). Fig. 2.5 depicts the interaction of 











The indicators for the healing of diseased periodontal tissues are the wound closure, cell 
migration and proliferation, connective tissue remodeling processes that involve the 
synthesis of extracellular components such as collagen, elastin, proteoglycans, and 
glycosaminoglycans.
108
 The healing process for the diseased periodontal tissues is 
complete once tissue homeostasis, i.e., the dynamic equilibrium between the matrix 
synthesis and destruction, is attained.  
2.4.1. Cells in Periodontal Wound Healing  
Fibroblasts are the most important cell type during periodontal wound healing processes 
as they function as key modulators in wound contraction and ECM remodeling.
109
  
Another cell type, macrophages, start the formation of the granulation tissue and release 
progenitor cells 
connective tissue cells 















numerous types of cytokines and growth factors.
107
 In addition, monocytes and platelets 
secrete platelet-derived growth factor (PDGF), which is essential for wound healing 
processes.
103
 Other cells involved in periodontal wound healing and their functions are: 
Inflammatory cells (polymorphonuclear leucocytes, lymphocytes, and plasma cells) 
secrete polypeptide mediators that stimulate new matrix formation; microvascular 




2.4.2. Growth Factors in Periodontal Wound Healing  
Periodontal wound healing is a complex biological process and requires the employment 
of a growth factor cocktail. Growth factors are proteins or polypeptides that can enhance 
the ability of the wounded tissues to regenerate while improving cellular chemoattraction, 
proliferation and differentiation.
111
 Growth factors regulate the biological processes 
during wound healing via binding to target cell surface receptors to activate transcription 
of specific genes through intracellular signaling pathways.
112, 113
    
Growth factors, particularly platelet-derived growth factor (PDGF) and insulin-like 
growth factor (IGF), have been shown to be actively involved in periodontal wound 
healing processes while stimulating the periodontal regeneration.
108
 PDGF is important in 
attracting neutrophils to the wound site to prevent bacterial contamination.
114
 The other 
important growth factors playing key role in the periodontal wound healing and 
regeneration processes are epidermal growth factors (EGF), fibroblast growth factors 






2.4.3. Proteoglycans in Periodontal Wound Healing  
Proteoglycans play a significant role in the matrix remodeling phase of periodontal 
wound healing.
117
 Among these molecules, decorin and syndecan have been reported to 
contribute to healing processes while regulating the activity of the growth factors.
118, 119
   
The cellular processes and key molecules that accelerate the healing process and improve 
periodontal wound repair are listed in Table 2.1.  
 







Chemotaxis PDGF, TGF-, FGF, IL-1, matrix products 
Adhesion Fibronectin, collagens, laminin, vitronectin 
Proliferation PDGF, FGF, IGF-I 
Differentiation ECM, growth factors, hormones 
Angiogenesis FGF, VEGF, TGF-, angiogenin 
Matrix synthesis, remodeling TGF-, IFN-*, TNF-, IL-1 
*







PERIODONTAL TISSUE ENGINEERING 
 
3.1. INTRODUCTION 
The aim of periodontal tissue engineering is to create and develop strategies to repair and 
regenerate the diseased tissues and form the replacement tissue. These strategies vary 
with the defect site, thus the tissue to be engineered. The periodontal tissue repair and 
regeneration techniques require the use of several cell types, scaffolds, growth factors and 
carefully designed bioreactor systems (Fig. 3.1). These components should all function in 
harmony to yield the desired outcome that enables tissue engineers to advance in the 







Figure 3.1. The main components in the creation of functional 3D tissue scaffolds. Appropriate 
cell sources, scaffold, signaling factors (e.g. growth factors, chemokines, cytokines) and the most 
suitable bioreactor system could help tissue engineers construct ideal replacement grafts.  










Current periodontal tissue engineering principles are based on step-by-step treatment of 
the diseased tissues. As the prior step, removal of the infected parts and microbial 
cleaning of these areas is required. Diseased periodontal tissues are accompanied with the 
diseased root surfaces which do not support the regenerative processes. Therefore, 
chemical agents (e.g. citric acid and tetracycline) in conjunction with mechanical 
conditioning are currently used to create biocompatible root surfaces for a new 
connective tissue attachment.
120-122
 The application of fibronectin on the acid-treated root 




Following the conditioning process, the appropriate combination of cells, scaffold, 
growth factors and bioreactor system is chosen to engineer the tissue construct with 
desired functions.   
3.2. CELLS IN PERIODONTAL TISSUE ENGINEERING 
Several types of cells have shown promise as candidate cells for periodontal tissue 
engineering, such as the cells derived from the gingiva, periodontal ligament (PDL) and 
alveolar bone,
123-127
 bone marrow stromal cells (BMCs),
128





 bone mesenchymal stem cells (BMSCs)
131
 and adipose-derived stem 
cells (ASCs)
132
. The soft and hard tissue repair processes require the synchronized 
functioning of gingival fibroblasts, gingival periodontal cells, PDL fibroblasts, 
cementoblasts and osteoblasts. The function of each cell type varies to a great extent, 
therefore, the specific focus will be given to the gingival fibroblasts and gingival 
epithelial cells in this section.  
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3.2.1. Gingival Fibroblasts 
Human gingival fibroblasts (hGFs) constitute the major cell population in gingival 
connective tissue. These cells resemble the periodontal ligament fibroblasts (PDLFs) in 
their characteristic in vivo spindle shape morphology (Fig. 3.2) and growth rates, 
however their functioning in maintaining ECM structure and during inflammation differs 
significantly.
133-135
 Somerman et al.
136
 examined the in vitro behavior of the hGFs and 
PDLFs isolated from the same patient at the same passage number and found PDLFs 
synthesized more collagen and demonstrated higher alkaline phosphatase activity. The 
same authors also reported that the two cell types showed differences in their response to 




                   
Figure 3.2. The spindle shape morphology of the hGFs as observed under light microscope. In 
culture, hGFs become very elongated when subconfluency is reached.  
 
The degree of interaction of the hGFs with any scaffold surface is influenced greatly by 
several factors, such as the surface roughness and morphology of the scaffold, 
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intracellular cytoskeleton components of the ECM (e.g. microtubules, intermediate 
filaments and microfilaments) and the integrin receptors of the cells.
138-141
 Pore size of 
the scaffold is also an important parameter, as currently it has been accepted that pore 
sizes smaller than 200 m inhibit the attachment and migration of the fibroblasts.
142
 
However, pathogenic bacterial invasion may also accompany the migration of the 
fibroblasts within the scaffold, which is considered an important limiting factor for 
achieving predictable periodontal regeneration.
143
  
The human gingival fibroblasts (hGFs), like all other cell types, regulate their activities 
by switching on and off the expression of their genes. The hGFs have been found to 
synthesize different ECM components (collagen, elastin, proteoglycans, etc.) as well as 




3.2.2. Gingival Epithelial Cells 
Gingival epithelial cells rapidly migrate apically (downward) into the wound site and 
complicate early wound healing processes and compromise the ultimate success of the 
regenerative therapy. Therefore, periodontal regeneration therapies aim to seek ways to 
prevent the migration of epithelial cells towards the wound space, thus allowing the 
selective repopulation of the wound site with the progenitor cells from the adjacent 
healthy periodontal ligament and alveolar bone tissue.    
On the other hand, gingival epithelial cells (keratinocytes), showing great resemblance to 
skin keratinocytes,
148
 have attracted the attention of periodontal tissue engineers that are 
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specifically interested in engineering oral substitutes. The aim is to treat the periodontal 
defects by creating oral mucosal substitutes that could replace the diseased or damaged 
tissue. Several studies have been reported in the literature.
149-151
 Basically, the tissue 
constructs are co-cultured with oral fibroblast cells and keratinocytes to fabricate oral 
tissue equivalents. Sanchez-Quevedo et al. (2007) populated their fibrin-agarose stromal 
substitutes with primary oral fibroblasts and keratinocytes by using the air-liquid culture 
technique (Fig. 3.3).
152
 This methodology promoted the stratification of the oral mucosal 
constructs’ epithelium while enhancing the healing process.  
 
                   
 
Figure 3.3. Air-liquid culture technique for the fabrication of oral mucosal substitutes.
152
 The oral 
fibroblast-embedded scaffolds are placed on a porous membrane, and the keratinocytes are 
seeded on top. The cells are co-cultured using the air-liquid culture technique to produce oral 





3.3. SCAFFOLDS IN PERIODONTAL TISSUE ENGINEERING 
Periodontal tissue engineering seeks innovative ways to introduce, improve and apply 
scaffolds for the therapy of periodontal disease. Ideally, a periodontal scaffold should not 
cause immunologic responses beyond those enabling wound healing, should be resistant 
to infection and should withstand the physiological forces upon implantation. Such 
scaffold should enhance fibroblast adhesion, proliferation and differentiation.
153
 The ideal 
scaffold should also have the desired surface/pore structure to promote migration/growth 
of cells, tissue in-growth, as well as the transport of nutrients and waste within the 
scaffold.
154, 155
 The scaffold’s ability to enhance vascular component formation for O2 
transport is another important issue. Additionally, the mechanical integrity of the scaffold 
should be in accordance with the biomechanical properties of the neighboring native 
tissue.
156
 All these considerations should be carefully taken into account while designing 
an optimum periodontal scaffold for the treatment of the periodontal disease. Different 
scaffolding technologies have been introduced to periodontal tissue engineering.  
3.3.1. Periodontal Grafting Materials  
An ideal periodontal grafting material should evoke the biological processes required for 
the regeneration of the defected periodontal tissues, and maintain the formation of a new 
tissue attachment. Several grafting materials have been used for the treatment of 





3.3.1.1. Autografts  
An autograft is a graft taken from one part of an individual and implanted to another part 
of the same individual. Cortical bone grafts and cancellous bone, marrow and bone 
blends are the commonly used periodontal autografts.
157, 158
 These grafts have proven to 
accelerate healing in terms of osteogenicity, osteoinductivity and osteoconductivity.
52
 
However, the need for a secondary surgical site on the patient to harvest bone tissue 
makes the use of autografts one disadvantage compared to allografts and xenografts. 
3.3.1.2. Allografts  
Allografts are grafts transferred between different individuals of the same species. Three 
types of bone allograft materials have found their application in clinical studies: (1) 
cancellous bone and marrow, (2) freeze-dried bone allografts, (3) demineralized freeze-
dried bone allografts.
37, 159
 Bone allografts are advantageous over autografts as they do 
not require a second surgical site on the patient to extract bone. However, the processes 
applied on the bone allografts to remove the immunogenic constituents could lead to a 
decrease in the osteoinductive and osteoconductive potential of the grafts.
52
 There is also 
a high incidence of pathogenic microorganism transfer with the use of allografts.
160
     
3.3.1.3. Xenografts  
Xenografts are surgical transplants taken from a different species. Bovine mineral matrix 
and bovine-derived hydroxyapatite (HA) are examples of commonly used xenografts in 
oral reconstructive surgeries.
161
 However, the applicability of xenograft materials remains 






Alloplasts are synthetic grafting materials used to treat the periodontal defect sites. The 
alloplastic materials commonly used in reconstructive periodontal surgery are the calcium 
phosphate ceramics- namely, the nonresorbable hydroxyapatites and the resorbable 
tricalcium phosphates.
163
 The main advantages of alloplastic grafts are their off-the-shelf 
availability and non-immunogenic nature. However, it has been reported that alloplastic 
materials did not support the cementogenesis process.
164
 
3.3.2. Guided Tissue Regeneration (GTR) Membranes 
Natural and synthetic materials are now used routinely in a wide variety of surgical 
procedures to isolate tissue compartments, direct cell migration, and in some cases 
provide a source of bioactive molecules to promote wound healing or regeneration. The 
goal to direct tissue regeneration has been extensively studied in periodontal defect repair 
surgery, where the aim is to regenerate components of the tooth supporting apparatus that 




The feasibility of periodontal guided tissue regeneration (GTR) was demonstrated in a 
proof of principle study in 1982,
167
 by employing a physical barrier interposed between 
the periodontal defect and overlying soft tissues (Fig 3.4). The concept was that the 
barrier provided a protected wound healing environment that excluded gingival epithelial 
and connective tissue cells that would regenerate soft tissues and inhibit bone repair. By 
limiting the wound site to undifferentiated mesenchymal cells that migrate from healthy 
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alveolar bone and the periodontal ligament, these cells are able to more effectively 




                
                 
 
Figure 3.4. Surgical application of the GTR membranes. A gingival flap reflecting the exposed 
root recession and healthy bone is created (A). Then, the barrier membrane is placed covering the 
root surface (B). The gingival flap with the keratinized tissue is repositioned while completely 
covering the membrane and sutured in position (C). Finally, the regeneration of the periodontal 
tissues, both physiologically and aesthetically, occurs with time (D) (www.dental-tribune.com). 
 
3.3.2.1. Non-Resorbable GTR Membranes 
A variety of non-resorbable materials have been used as physical barriers, the first being 
expanded poly-tetrafluoroethylene (e-PTFE) (Gore-Tex, W.L. Gore & Assoc., Inc., 





applications. While this material has produced favorable clinical results in periodontal 
regeneration,
169, 170
 it requires an undesirable second operative procedure for removal, 
and is associated with a high incidence of post-operative complications.
171-173
 
3.3.2.2. Resorbable GTR Membranes 
The second generation of physical barriers focused on resorbable membranes that avoid 
the need for a second surgical intervention while meeting the additional demands 
involved in the bioresorption process, such as Bioguide (Osteohealth Co., Shirley, NY) 
and Biomend (Sulzer Medica, Colla-Tec, Inc., Plainsboro, NJ), both of which consist of 
processed xenogenic collagen.
174, 175
 More recent approaches have included human-
derived intact tissue complexes including acellular dermal matrix (Alloderm, LifeCell 
Corp., Branchburg, NJ) and pericardium (Pericardium, Tutoplast, Neunkirchen, 
Germany).
176-180
 Despite its favored polar structure allowing epithelial cell attachment on 
the basal side and fibroblast penetration and growth on the other side, the need for tissue 
donated from a human source remains a limiting factor with Alloderm.
181
  
While a number of clinical studies have documented the effectiveness of periodontal 
GTR,
182-186
 few studies have reported the long-term outcome of these therapies.
187
 In 
addition, the predictability of these procedures is currently less than ideal, varying with 
local anatomy, patient characteristics, and other unknown factors.
188-190
 Thus, the 
biological requirements for periodontal regeneration are not yet completely understood 




3.4. GROWTH FACTORS IN PERIODONTAL TISSUE ENGINEERING 
Various growth factors have been employed to stimulate the regeneration of periodontal 
defects. Platelet-derived growth factors (PDGF)
191
 (PDGF-AA, PDGF-BB, PDGF-AB, 
vascular endothelial cell growth factor), epidermal growth factors (EGF) (epidermal 
growth factor, transforming growth factor-, amphiregulin), fibroblast growth factors 
(FGF) (acidic fibroblast growth factor (FGF-1), basic fibroblast growth factor (FGF-
2)
192
), insulin-like growth factors (IGF)
193
 (IGF-I, IGF-II), transforming growth factors 
(TGF) (TGF-,
194
 bone morphogenetic proteins
195
) have been introduced as candidate 
growth factors for periodontal tissue engineering.  
3.5. BIOREACTORS IN PERIODONTAL TISSUE ENGINEERING 
Bioreactor technologies for dynamic culture of tissue constructs provide an aseptic 
culture environment where the temperature, pH, nutrients (e.g. glucose, amino acids), 
gases (O2 and CO2) and growth factors are homogenously distributed for the cells to 
proliferate and differentiate.
196
 Besides their function to overcome the problems 
associated with the concentration gradients of these components, the mechanical 
stimulation created by such systems enable tissue engineers to develop various 
scaffolding materials for different applications.  
While designing a bioreactor system, it is essential to keep the level of in vitro operating 
parameters close to physiological conditions. Bioreactor cultures with the appropriate 
design conditions have been reported to enhance the synthesis of the necessary ECM 
components by the seeded cells.
197
 The perfusive flow created by these bioreactors 
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provided a culture environment where the ECM synthesis is enhanced, mass transfer 
limitations of the necessary nutrients and gases were reduced, and the appropriate 
physical stimuli contributed to the organization of the ECM components.
198
   
To date, little emphasis has been placed on the design of a bioreactor system for the 
cultivation of oral mucosal substitutes or periodontal grafts,
199
 as such exploration of 
ideal culture conditions and development of suitable periodontal grafts using advanced 















CHARACTERIZATION OF PORCINE ORAL SOFT TISSUES AS A 
MODEL SYSTEM  
 
4.1. INTRODUCTION 
Oral soft tissues are complex biological systems with the components of their 
extracellular matrix (ECM) responding differentially to physiological stresses. These 
tissues are subjected to a wide variety of mechanical forces, including hydrodynamic 
forces, compression, elongation, friction, and shear generated during saliva flow, 
mastication, speech, toothbrushing, etc.
200-203




Among the oral soft tissues, the attached gingiva, alveolar mucosa, and the buccal 
mucosa have attracted the most attention due to controversy among clinicians regarding 
the necessity and/or quantity of keratinized gingiva to support health around natural teeth 
and dental implants.
205-207
 The mucogingival junction demarcates the attached gingiva 
from the alveolar mucosa, which, on the buccal side of the cheek, transitions to the buccal 
mucosa.
208
 The surface of all three mucosal tissues is covered with a stratified squamous 
epithelium that is bound to the underlying connective tissues by a network of anchoring 
fibrils.
53, 209
 Most gaseous and metabolic substance exchange is maintained through the 
junction between the epithelial and connective tissues.
210
 On the other hand, the 
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epithelium represents the barrier to the oral tissues that limits the diffusion of the tissue 
fluids out, and prevents the migration of the toxic substances through the tissue.
211
   
The ultrastructure of the different oral soft tissues is in accordance with their specific 
function within the oral cavity. The attached gingiva which is directly influenced by 
strong mechanical forces, especially during mastication, is firmly attached to the 
underlying cementum and alveolar bone.
212
 In addition, the highly keratinized nature of 
the stratified epithelium enables the tissue to resist deformation forces.
213
 Conversely, the 
alveolar and buccal mucosas, which have a reduced exposure to abrasive forces, are 




Besides the ultrastructural changes between the attached gingiva and the adjacent 
alveolar mucosa, the existence of a temperature gradient through the mucogingival 
junction has also been reported.
216
  Volchansky et al. (1994) also reported a difference in 
temperature between the oral mucosal tissue and the underlying bone.
217
 
From both materials development and clinical perspectives, a quantitative mechanical 
analysis of oral soft tissues is essential if new materials are to be developed that mimic 
the behavior of natural tissues. This is particularly important from a clinical perspective 
where there is ongoing debate regarding the necessity of a band of keratinized gingival 
tissue to surround natural teeth and dental implants.  
In the current literature, an extensive research has been conducted on the mechanical 
properties of the periodontal ligament (PDL) and the bone tissue.
218, 219
  However, there is 
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little descriptive analysis of the oral soft tissues, especially details of the biomechanical 
properties and regional variations in performance. Kydd et al. (1967) investigated the in 
vitro tensile properties of human gingiva using an extensometer and reported the low and 
high elastic moduli of the human ginviva to be 2.76 ± 0.95 and 10.20 ± 0.40 dynes/cm
2 
(mean ± standard deviation (SD)), respectively.
220
 This study aims to characterize the in 
vitro biomechanical behavior of porcine tissues as a representative model system due to 




4.2. MATERIAL AND METHODS 
      4.2.1. Sample Preparation 
The lower jaws of 25 freshly slaughtered 6-9 month-old pigs were obtained from Animal 
Technologies Inc. (Tyler, Texas). Oral tissues, including the buccal attached gingiva 
(BAG), buccal alveolar mucosa (BAM), buccal mucosa (BM), lingual attached gingiva 
(LAG), and lingual alveolar mucosa (LAM) were excised using sharp dissection from 
porcine lower jaws within 24 hours of animal sacrifice (Figs. 4.1A, 4.1B). The complete 
soft tissue complex was dissected from epithelium to bone, including the periosteum. The 
excised tissue was stored in phosphate-buffered saline (PBS) containing 0.03 M 
potassium phosphate monobasic (Merck, Darmstadt, Germany), 0.12 M sodium 
phosphate dibasic (Mallinckrodt Baker, Inc., Phillipsburg, NJ), and 0.2% penicillin 





      
Figure 4.1. Porcine oral soft tissues extracted from the buccal (A) and lingual (B) aspects of 
porcine lower jaws. BAG, buccal attached gingiva; BM, buccal mucosa; MJ, mucogingival 
junction; LAG, lingual attached gingiva; and LAM, lingual alveolar mucosa.    
 
4.2.2. Uniaxial Mechanical Testing  
The mechanical properties (tensile, viscoelasticity, and dynamic compressive) of the 
porcine oral soft tissues were assessed using an Instron mechanical testing machine. For 
the dynamic compression tests, the tensile testing rig of the Instron mechanical tester was 
replaced with top and bottom compression plates (Fig. 4.2).  
 
                
 
Figure 4.2. The tensile (A) and compression testing (B) of the porcine oral soft tissues was 




4.2.2.1. Tensile Testing 
Tensile analysis was carried out using an Instron 5543 testing machine (Instron Corp., 
Norwood, MA) equipped with a 50-N load cell. Tissue strips 3 x 30 mm (n = 9) were 
maintained in PBS until the mechanical testing to prevent dehydration.
222
 Samples were 
secured in the grips of the tensile testing rig using #100 grit sandpaper with cyanoacrylate 
adhesive (Loctite, Henkel Loctite Co., Ireland).
223
 The aspect ratio of the tissue strips was 
maintained at a minimum of 6:1 to ascertain a homogeneous stress-strain state.
224
 Tissue 
strips were preloaded to 0.003 N at a cross-head velocity of 5 mm/min, then 
preconditioned to achieve a steady response with 5 repeated load/unload cycles at an 
extension rate of 5 mm/min.
225, 226
 Finally, the strips were stretched to failure at an 
extension rate of 5 mm/min.
227
 Load and displacement data was the recorded, with the 
stress-strain relationship and tensile properties of the HUV strips deduced from the 
acquired data. 
Prior to testing, the thickness of the tissue strips (n = 9) was measured as 1.31 ± 0.26 mm 
(mean ± standard deviation (SD)) (lingual attached gingiva), 1.60 ± 0.20 mm (buccal 
attached gingiva), 1.95 ± 0.42 mm (lingual alveolar mucosa), 2.45 ± 0.25 mm (buccal 
alveolar mucosa), and 2.96 ± 0.38 mm (buccal mucosa). 
From the load-displacement data, tensile stress (MPa) was calculated by normalizing the 
tensile load (N) to the tissue cross-sectional area (3 mm  tissue thickness). Tensile strain 
was computed by normalizing the displacement data to the tissue section’s original gauge 
length. Young’s modulus (MPa) was calculated as the slope of the linear region of the 
stress-strain curve, whereas the ultimate tensile strength (MPa) was determined as the 
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maximum attainable stress of the stress-strain curve. Failure load (N) was expressed as 
the maximum load sustained at fracture, and the strain at failure was computed from the 
displacement corresponding to failure load. 
4.2.2.2. Stress Relaxation 
Regional variation in tissue viscoelasticity was assessed by stress relaxation analysis. 
Each tissue strip was mounted in the mechanical testing machine and preconditioned, as 
described above. Samples (n = 8) were loaded to one-third of the force at fracture at an 
extension rate of 30 mm/min and then the cross-head was stopped immediately to unload 
the sample.
226
 Stress was normalized to the initial stress and plotted versus time. The 
initial stress,  at t = 0 and the equilibrium stress,  were recorded after relaxation was 
initiated. The contribution of the viscoelastic stress to the total stress, (-)/ was 
assessed to characterize the viscoelasticity of each region.
222
 
During tensile and stress relaxation tests, the porcine specimens were maintained in a 




4.2.2.3. Dynamic Compression  
In order to mimic the chewing movement of mammalians, dynamic compression tests 
were performed on the porcine tissues.
229
 Using the same uniaxial mechanical testing 
machine, tissue sections were compressed between the two metal compression plates by 
cyclic displacements of the top indentor. Dynamic behavior of the tissues was assessed 




frequencies, 0.1 Hz, 0.5 Hz, and 1 Hz. 5 mm-diameter tissue disks were excised from 
each location and glued onto a Petri dish which was then filled with PBS until the tissue 
was covered. The mean thickness of the unloaded disks (n = 6) was the same as stated in 
the uniaxial testing section. The tissue thickness within each tissue region group was kept 
the same since it has been reported that the degree of recovery of the tissue upon 
compression was significantly dependent on the tissue thickness.
230
 Then, excess 
moisture was removed from the bottom surface of the specimen, then glued using 
cyanoacrylate adhesive onto a Petri dish (which was glued onto the bottom compression 
plate).  The Petri dish was then filled with PBS (0.15 M, pH 7.4) until the sample was 
covered in order to mimic the hydrated physiological environment. Compressive force 
and displacement was measured instantaneously with a sampling rate 500 ms; range 50 
N, and accuracy  0.25%. Compressive strain, , was defined as the displacement of the 
top indenter (h) relative to the initial thickness of the disk between the compression 
plates (h0). Compressive stress, , was computed as  = F/A, where F and A represent the 
compressive load and the tissue cross-sectional area, respectively.
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The time dependency of the tissue behavior was assessed after 25 compression cycles, 
then after a recovery time of 5 min, a trial series of tests was conducted under different 
amplitude-frequency combinations. The series was repeated in reverse order for the same 
region. Both series showed similar results indicating the testing order and time had no 





The dynamic compressive properties, instantaneous modulus (Eint) and steady modulus 
(Es) were computed as the peak stress values at the first and last compression cycle 
relative to the corresponding compressive strain.
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4.2.3. Histological Analysis Using Light Microscopy 
Tissue samples from different regions (n = 6) were fixed in 3.7% formalin (tissue:solvent 
ratio was 1:40 (v:v)) overnight. The samples were placed in 70% ethanol (EtOH) solution 
in distilled water until the analysis. Prior to analysis, the sections were put in tissue 
cassettes and the cassettes were labeled. The tissue sections in cassettes were subjected to 
a dehydration step at 45C (80% EtOH (1×), 95% EtOH (2×), 100% EtOH (3×), 30 min 
for each step). After the dehydration step, tissue sections were placed in Clear-Rite 
reagent to clear the tissue (2×, 30 min for each). The sections were then infiltrated with 
melted paraffin at 60C (2×, 1 hr for each). This was followed by soaking the tissue 
samples in paraffin bath under vacuum for 1 hr to ensure paraffin penetration within the 
tissue. The tissue sections were then removed from the cassettes and paraffin-embedded 
using a Tissue-Tek II Tissue Embedding Center (Miles Laboratories, Inc., Westmont, IL). 
Paraffinized samples were gradually freezed down to -80C and were kept at that 
temperature until sectioned (at least 24 hr). Samples were sectioned to 5 µm on a Leitz 
1512 microtome (Leitz, Oberkochen, Germany). The tissue sections were placed on 38C 
water bath and mounted on glass slides, and then kept in 60C for 2 hours. The samples 
were then deparaffinized by soaking in Clear-Rite (3×, 3 min each), and rehydrated 
through decreasing alcohol concentrations (100%, 95%, 80%, 70% EtOH, 1 min each). 
The sections were then stained with Hematoxyline (Richard-Allan Scientific, Kalamazoo, 
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MI) for 7 min, cleared in 1% acid alcohol solution (hydrochloric acid (HCl)/EtOH) for 5-
10 sec and immersed in 0.2% ammonia-water solution for 20 sec, and counterstained 
with Eosin-Y (Richard-Allan Scientific, Kalamazoo, MI) with a few drops of glacial 
acetic acid (J.T. Baker, Phillipsburg, NJ) for 5 sec. The stained sections were then 
dehydrated through increasing alcohol concentrations (95% EtOH, 2×, 1 min each, 100% 
EtOH, 2×, 1 min each), and immersed in Clear-Rite (2×, 1 min each). The stained 
sections were mounted and secured with cover slips and left at room temperature 
overnight. The sections were then histologically assessed to visualize structural variation 
using a Nikon Eclipse E800 Epifluorescent upright microscope (Nikon, Melville, NY). 
The analysis of the histological images was done using the MetaMorph software V6.2 
(Molecular Devices, Downingtown, PA). 
4.2.4. Data Analysis 
Statistical analyses were performed using the SPSS 15.0 software (SPSS Inc., Chicago, 
IL). One-way univariate analysis of variance (ANOVA) was used to test for significant 
differences among multiple test groups. Multiple comparisons between groups were 
performed with the Games-Howell or Tukey post hoc tests depending on homogeneity of 
variance tested with Levene’s test. A three-way univariate ANOVA was also carried out 
to demonstrate the interaction between region, strain frequency (0.1, 0.5, and 1 Hz), and 
strain amplitude (5, 10, and 15%) affecting the instantaneous modulus (Eint) and steady 
modulus (Es). Statistical significance was set at p < 0.05 for all tests. All values are 





4.3.1. Assessment of Tissue Mechanics 
4.3.1.1. Tensile Properties 
The representative stress-strain curves (Fig. 4.3) exhibited characteristic behavior of soft 
connective tissues.
233
 Stress-strain data was derived from the load-displacement data by 
normalizing the force values with the tissues cross-sectional area. 
 
 
              
 
Figure 4.3. Representative stress-strain curves for different regions of porcine oral mucosal tissue 
in uniaxial tensile testing (n = 9). 
 
 
The ultimate tensile strength of the buccal attached gingiva (3.94 ± 1.19 MPa) was 
similar to that of the lingual attached gingiva and this strength value was significantly 




      
 
Figure 4.4. Ultimate tensile strength. Attached gingiva demonstrated the highest ultimate strength 
among all the regions tested (n = 9, Games-Howell, p < 0.05). LAG, lingual attached gingiva; 






The buccal attached gingiva exhibited the highest stiffness with a Young’s modulus value 
of 19.75 ± 6.20 MPa, which was significantly higher than the alveolar mucosa (of both 
lingual and buccal aspects), as well as the buccal mucosa (p < 0.005). However, there 
was no significant difference in stiffness between the lingual and buccal aspects of the 







TABLE 4.1. TENSILE PROPERTIES OF THE PORCINE ORAL SOFT TISSUE  
 TENSILE PROPERTIES
* 


















Lingual alveolar mucosa (LAM) 4.79  2.54
a,b
 0.88  0.19
a,b,d
 10.54  2.18
b
 
Buccal alveolar mucosa (BAM) 5.74  1.15
a,b,e
 0.51  0.08
a-c,e
 8.93  2.06
b
 
Buccal mucosa (BM) 2.48  0.37
a,b,d
 0.94  0.06
a,b,d




 Data are mean ± standard deviation (n = 9). Pairwise comparisons (statistical significance set at 











versus BM.  
 
 
4.3.1.2. Viscoelasticity  
Stress relaxation curves for the porcine tissue (Fig. 4.5) displayed a typical nonlinear 
viscoelastic oral soft tissue response, as the stress within the tissue decayed over time 
until equilibrium values were reached.
234, 235
 The normalized stress reached a steady value 




           
 
Figure 4.5. Normalized stress relaxation curve. The stress at each time point was divided by the 
maximum stress to yield the normalized stress values for the relaxed tissue strips. Lingual 
alveolar mucosa demonstrated significantly higher viscoelasticity compared to the lingual and 




The lingual alveolar mucosa demonstrated a significantly higher viscoelasticity compared 
to the attached gingiva (lingual and buccal), as well as the buccal mucosa (n = 8, p < 
0.05). The viscoelastic properties of the lingual and buccal alveolar mucosa were found 
to be statistically similar. The mean (± SD) values for the initial stress (), equilibrium 








TABLE 4.2. STRESS RELAXATION DATA OF THE PORCINE ORAL SOFT TISSUE  
 STRESS RELAXATION DATA
* 
REGION Initial Stress, 0 
(MPa) 
Equilibrium 
Stress,  (MPa) 
(0 - )/ 0
+ 












Lingual alveolar mucosa (LAM)  0.25  0.03
a,b,e
 0.1  0.01
a,b,e
  0.59  0.04
a,b,e
 
Buccal alveolar mucosa (BAM)  0.21  0.02
a,b,e
 0.09  0.01
a,b,e
 0.56  0.06
a,b
 
Buccal mucosa (BM) 0.39  0.03
a-d
 0.19  0.03
a-d




Data are mean ± standard deviation (tensile, n = 9; stress relaxation, n = 8). Pairwise 





 versus BAG; 
c
 versus LAM; 
d
 versus BAM; 
e
 versus BM.  
+





4.3.1.3. Dynamic Compressive Properties 
A representative graph of compressive stress versus time is shown in Figure 4.6A. At 
10% strain and 1 Hz frequency the buccal attached gingival displayed the highest peak 
stress values, after which the stress of each subsequent cycle decreased to a steady-state 






Figure 4.6. A representative graph of compressive stress versus time for the buccal attached 
gingiva at 10 % strain and 1 Hz frequency, with the first cycle generating the largest peak, after 
which the peak stress value of each cycle decreased to a steady-state value (A). The percent strain 
remained constant for the subsequent cycles (B).  
 
The peak stress values, i.e., the maximum compressive values attained during the first 
compression cycle for tissue regions were displayed in Fig. 4.7. The peak stress exhibited 
by the buccal attached gingiva (1.17 ± 0.17 MPa) was similar to the peak stress of the 
lingual attached gingiva, and this peak stress value was significantly higher than all the 
other regions tested (p < 0.001). There was also no significant difference in peak stress 




         
 
Figure 4.7. Peak stress. Maximum stress values for each tissue section during the initial 
compression cycle at a frequency of 1 Hz and strain amplitude of 15%. LAG, lingual attached 
gingiva; BAG, buccal attached gingiva; LAM, lingual alveolar mucosa; BAM, buccal alveolar 
mucosa; BM, buccal mucosa.Values are means and standard deviations (n = 6). 
*
 indicates 




In general, both the instantaneous modulus (Eint) and the steady modulus (Es) increased 
with strain amplitude and loading frequency (Figs. 4.8 and 4.9). The buccal attached 
gingiva was shown to have the highest Eint and Es values, 7.81 ± 1.11 MPa and 0.86 ± 
0.09 MPa, respectively (1 Hz, 15% strain). Both instantaneous modulus (Eint) and steady 
modulus (Es) were significantly influenced by region, frequency and strain amplitude 




     
 
      
 
                                  
 
Figure 4.8. Instantaneous modulus (Eint), a measure of the contribution of the tissue collagen and 
proteoglycans to the compressive stiffness at the initial cycle, was dependent on strain amplitude 
and loading frequency; , 5% compressive strain; ■, 10% compressive strain; ▲, 15% 
compressive strain. Data are means ± standard deviations, n = 6.  
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Figure 4.9. Steady modulus (Es), measure of tissue compressive stiffness at the last cycle when 
the stress equilibrates, was also influenced by the strain amplitude and loading frequency; , 5% 
compressive strain; ■, 10% compressive strain; ▲, 15% compressive strain. Data are means ± 
standard deviations, n = 6. 
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4.3.2. Histological Assessment 
The histological analysis showed that the organization of the epithelial and connective 
tissues varied considerably among different regions. Representative images (n = 6) 
showed the epithelium of the attached gingiva in both lingual (Fig. 4.10A) and buccal 
(Fig. 4.10B) aspects to be bound with a clear margin, the stratum corneum (SC), which 
indicates the keratinization of the tissue. However, such a boundary layer was absent for 
the epithelium of the buccal mucosa (Fig. 4.10C) and the alveolar mucosa (Figs. 4.10D, 
4.10E). The histology also showed the keratinized surface layer, stratum corneum (SC), 
of the attached gingiva to be orthokeratinized displaying a loss of epithelial cell nuclei, 
whereas the cells of the non-keratinized regions retained their nuclei. Both lingual and 
buccal attached gingiva display a well-defined stratum granulosum and basal layer, or 
stratum basale, with characteristic protrusions intertwined with the underlying connective 
tissue. As expected the histological analysis shows the buccal mucosal epithelium to be a 
relatively thick layer (>0.5 mm) compared to the epithelia of the attached gingiva and 





         
             
                                                                   
                     
Figure 4.10. Histological analysis (hematoxylin and eosin, original magnification 10) shows the 
keratinized epithelium of the lingual (A) and buccal (B) attached gingiva. The non-keratinizing 
epithelial layers of the buccal mucosa (C), lingual alveolar mucosa (D), and buccal alveolar 
mucosa (E) were also observed from the histology images. The connective tissue (CT), 
epithelium (E), and stratum corneum (SC) show the relative thicknesses and ECM structure of 




4.4.  DISCUSSION 
These investigations assessed the biomechanical behavior of oral soft tissues under 
applied stress conditions, and evaluated mechanical variation as a function of tissue 
location. A more detailed knowledge of the properties of these tissues, in particular 
functional and regional variations, will provide an important baseline for the development 
of improved materials to repair or regenerate these soft tissues. Because of the limited 
data available on the biomechanical properties of human oral soft tissues and the 
resemblance of porcine oral tissues to human tissue,
236
 porcine tissues were used as a 
model system in this ex vivo study. The biomechanics of the porcine oral soft tissues were 
examined under compressive and extensional forces. The compressive properties of the 
tissue were investigated under dynamic compression simulating the forces acting on oral 
tissue during mastication. Although the chewing frequency of the pig ranges between 2-3 
Hz, the compression tests in this study were carried out over a frequency range of 0.1-1 
Hz which corresponds to the chewing frequency of humans.
237
  
Results from the investigations described herein show that the biomechanical behavior of 
the porcine oral mucosa displays significant regional variation directly related to unique 
structural and functional characteristics of these different tissues. The attached gingiva 
demonstrated the highest tensile and compressive strength amongst all tested regions, and 
has been assumed to be a consequence of structural adaptations of the ECM.
53
 Consistent 
with the literature, cells in the attached gingiva’s keratinized stratum corneum (SC) layer 
were devoid of nuclei, instead displaying a dense network of keratin filaments. This 
directly results in the increased tensile stiffness and strength relative to zones more 
51 
 
distant to the tooth/gingiva junction.
238
 The higher mechanical strength of the attached 
gingiva was also attributed to its collagenous fibers within the connective tissue layer. 
The higher tensile strength of the attached gingiva was also attributed to more abundant 
collagenous fibers within the connective tissue layer, relative to the buccal mucosa with a 
higher epithelial tissue content displayed a lower tensile strength. Connective tissue 
collagenous fibers are also known to be more organized in the attached gingiva.
239
 The 
epithelial tissue layer thickness values obtained for each representative tissue layer are 
consistent with those reported in the previous studies.
240-242
   
Viscoelastic properties of the tissue were detailed using stress relaxation analysis and 
were found to be consistent with the tissues physiological demands, where repetitive jaw 
movement and mastication require highly distensible tissue in order to perform 
appropriately. These results also show the alveolar mucosa to have a relatively high 
viscoelasticity compared to the other regions. This result can be attributed to several 
factors, including the abundant and densely arranged elastic fibers,
225
 epithelial 
mucopolysaccharides reducing tissue deformation under load,
243
 and the ease of 
movement of the interstitial fluid within the ECM.
231, 244
  
The dynamic compressive properties of these tissues were shown to vary significantly 
amongst different regions of porcine oral mucosa, in particular the attached gingiva was 
shown to have higher compressive modulus values relative to the other regions. The 
attached gingiva is directly affected by compressive forces due to location and thus 
structural adaptations and composition correlate with the strong compressive forces 
during mastication.
245
 The attached gingiva with its keratinized epithelial layer resists 
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these compressive stresses more compared to the other regions, and transmits the applied 
stress to a lesser extent to the underlying connective tissue. The higher compressive 
strength of the attached gingiva may also be likely due to its higher collagen and 
proteoglycan content in its ECM.
246
 Proteoglycans manage to absorb and release 
sufficient tissue water for varying compressive strain and frequency values, while the 
collagen fibers assist the movement of tissue fluid during compression.
231, 247, 248
 The 
collagen fibers of the connective tissue layer were previously reported to realign to a 
position parallel to the underlying epithelial layer upon compression.
249
 Kydd et al. 
(1971) also demonstrated that morphological changes occurred within the connective and 
epithelial tissue layers of the masticatory mucosa under compressive load.
250
 
Although several investigations have shown variation in composition between the lingual 
and buccal aspects of oral mucosa,
251, 252
 the results reported here showed no significant 
differences in their response to applied in vitro stresses. Further, no significant 
differences in mechanical strength were found between the lingual and buccal aspects of 
the attached gingiva. The close resemblance in biomechanical properties is primarily 
driven by the anatomical similarities between the two aspects, as shown in the 
histological analyses.  
Although human and porcine oral tissues are similar in many respects and porcine tissues 
have been shown to be a useful and a relevant model to draw conclusions about human 
soft oral tissue function,
253
 some variation is observed. Human tissues typically display 
am increase in collagen and non-collagenous protein content and higher concentrations of 
DNA relative to the equivalent porcine tissue.
96, 254, 255
 As such, caution must be advised 
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for direct extrapolation of human tissue performance. Variation in animal model data to 
human oral soft tissues have shown different systems to exhibit higher than expected 
biological variation and poor reproducibility.
256
 In addition, gross anatomy, mastication 
mechanics, and dietary composition may have a more direct effect on these tissues 
performance relative to humans. 
4.5. CONCLUSIONS 
The data reported in this study support our hypothesis that the mechanical properties of 
oral soft tissues show significant variation in performance as a function of structure and 
location in the oral cavity. Although it remains to be established what biomechanical 
properties are minimally necessary to support mastication and other oral functions, the 
results reported in this study clearly indicate that attached gingiva is significantly stiffer 
and more resistant to mechanical stresses than regions of non-keratinized oral mucosa. 
The biomechanical testing results presented herein may have important clinical 
implications in human systems, where a deeper understanding of periodontal tissue 
biomechanics may enhance the success of soft tissue graft procedures by improved tissue 
pairing. By allowing surgeons to better select donor tissue location to be more 
biomechanically consistent with the implantation site may lead to improved tissue 
grafting outcomes. Mechanical mismatching has been shown to be predictive of failure of 
other tissues,
257-259
 however further investigation is required to fully assess the effect of 
mechanical pairing tissues in the oral environment. In addition, a thorough understanding 
of functional tissue mechanics will set basic targets for biomedical engineers to develop 




HUMAN UMBILICAL VEIN (HUV) AS A NOVEL GRAFT FOR 
PERIODONTAL TISSUE ENGINEERING 
 
5.1. INTRODUCTION 
The human umbilical cord (HUC) is a natural tissue complex that is readily available as 
discarded tissue from birthing centers at an average length of 50-60 cm,
260
 and free of 
valves and branches.
261
 The HUC consists of two human umbilical arteries (HUAs), one 
human umbilical vein (HUV), and the surrounding Wharton’s Jelly. The HUA is longer 
than the HUV, and as the difference becomes larger, it gives the cord a twisted shape.
262
 
The histological cross-section of the HUC is presented in Fig. 5.1. The HUC also consists 
of numerous growth factors and various types of cells in its structure, such as autologous 
cell sources and mast cells involved in immunological and inflammatory reactions.
31, 263-
267






              
Figure 5.1. (A) Schematic diagram showing the fetal circulatory system. The fetus is connected 
to the placenta by the umbilical cord. The blood vessels within the umbilical cord provide the 
transportation of the necessary nutrients and oxygen to the fetus, and the waste products back to 
the mother’s circulation system (www.health.uab.edu). (B) Hematoxylin & Eosin (H&E) staining 
of the human umbilical cord (HUC) showing the two arteries, one vein and the surrounding 
matrix, Wharton’s Jelly.  
 
The human umbilical vein (HUV), having a diameter of approximately 4-6 mm,
268
 has 
been successfully used as a glutaraldehyde-treated graft for reconstructive vascular 
surgeries showing improved patency rates in small diameter applications.
269-274
 The 
glutaraldehyde-treatment (tanning) process cross-links collagen fibrils to strengthen the 
material,
275, 276
 tends to block the immunogenicity,
273
 helps to prevent the degradation of 
the graft,
277
 and completely de-endothelializes the lumenal surface.
278
 The major problem 
with this chemical modification is the aneurysm formation within the graft.
279-281
 The 
complete removal of glutaraldehyde from the grafts prior to implantation is also 
necessary due to its thrombogenicity and cytotoxicity.
282, 283
 However, unmodified or 
untanned HUV grafts are subject to destruction by host-immune reaction.
284
 To improve 











 It has been hypothesized that the collagenous tissue structure remained 
after the decellularization process would retain the tissue characteristic biomechanical 
properties and provide a suitable background for growing new tissue architecture.
289
  
Decellularization alters the scaffold’s composition, surface chemistry and ultrastructure, 
thus influencing cell attachment, viability, proliferation and gene expression for various 
ECM proteins.
290
 Among the decellularization agents, sodium dodecyl sulfate (SDS) is 
one of the most widely used anionic surfactants because of its efficacy in removing 
xenogenous cells, solubilizing membrane proteins, and preserving tissue ultrastructure 
and mechanical integrity.
291-293
 Use of SDS, nevertheless, needs some precautions, since 
the ineffective removal of the surfactant may inhibit the growth of the reseeded cells.   
Taking advantage of the HUV’s natural structure and composition, a number of other 
surgical applications are foreseen, particularly as a resorbable (non-crosslinked) 
material.
227, 294
 The HUV is readily dissected from the cord and can be split longitudinally 
to form a flat sheet, approximately 18-20 mm wide, that may offer a unique approach to 
periodontal GTR. The HUV is allogenic which potentially reduces immune reactivity 
compared to xenogenic materials and also the risk of interspecies viral transfer. Its 




The biofunctionality of HUV can be attributed, in part, to its multilayered composite 
structure, which provides unique composition, architecture, and mechanical properties. 
This structure is consistent with other blood vessels, having an intima with an endothelial 
cell layer and basement membrane that separates the medial layer with an internal elastic 
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lamina composed of longitudinally-oriented elastin fibers.
297, 298
 The medial layer is 
approximately 200-350 μm thick and represents the primary load-bearing layer, that 
resists pressure induced by blood flow.
30, 222
 The medial layer is populated with large 
numbers of smooth muscle cells dispersed within collagen bundles densely interwoven 
with a meshwork of thicker elastin fibers, and smooth muscle layers.
26, 299
 Collagen fibers 
are relatively strong and stiff, compared to elastin fibers that are more extensible.
300
 The 
transitional region between the media and adventitia consisted of individual collagen, 
fibroblasts, fibroblast-like cells and smooth muscle cells sparsely distributed within the 
tissue.
301
 The less structured adventitia contains only a few elastin fibers with most of its 
collagen I fibrils arranged circumferentially around the vessel.
298, 302, 303
 The adventitia 
layer integrates into a supporting loose connective tissue unique to the HUV, Wharton’s 
Jelly, a mesenchymal matrix consisting of sulphated glycosaminoglycans, and 
proteoglycans (PG), covalently attached to the sulphated glycosaminoglycans (sGAG).
304
 
sGAGs mainly contribute to the permeability properties of the connective tissue,
305
 while 
the hyaluronic acid (HA), the most abundant sGAG, helps the Wharton’s Jelly maintain 
its hydrated state.
306
 The PGs of Wharton’s Jelly form anti-thrombogenic barrier in the 
vascular lumen.
24
 These structures are immobilized in a collagen fibril-glycoprotein 
microfibril network with dispersed cell populations.
284, 307-309
 The loosely arranged 
collagen fibrils lack a systemic orientation in this layer, whereas their orientation 
becomes circular for the large umbilical cord vessels.
20, 310
  
Given these properties, we envision that in the case of periodontal GTR, the relatively 
porous ablumenal surface of the tissue-engineered HUV scaffold, composed of collagen 
types I and III and hyaluronic acid could be implanted against the periodontal defect, and 
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the gingival flap positioned over the less porous lumenal surface, composed of a type IV 
collagen basement membrane (Fig. 5.2). Used in this manner, the decellularized HUV 
matrix may fulfill the requirements for periodontal GTR by providing adequate space for 
blood clot formation, wound stabilization, and encouraging repopulation of the wound by 
appropriate progenitor cells.
311
 Similar scenarios could be suggested for other surgical 
procedures that utilize such a barrier. To the author’s knowledge, this paper represents 
the first time the HUV has been investigated as a surgically implantable biomaterial 
outside vascular applications. 
 
                                     
Figure 5.2. A diagram of the proposed surgical application for a periodontal defect, where the 
human umbilical vein (HUV) matrix is inserted under the existing gingiva. 
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Any material to be used as a surgical barrier must have sufficient mechanical properties 
to withstand forces that would be encountered clinically, and also biological properties 
that allow appropriate interaction with local tissue cells.  
These investigations outline the potential of the HUV as a barrier matrix, biomechanical 
properties and the ability of the matrix to support the growth and proliferation of human 
gingival fibroblasts (hGFs). These results suggest that the HUV may have potential as a 
novel biocompatible matrix for use as a barrier in periodontal GTR and other surgical 
techniques that employ a barrier membrane.  
5.2. MATERIALS AND METHODS 
5.2.1. Preparation of Human Umbilical Vein (HUV) 
Human umbilical cords were obtained from the Delivery Suite of Norman Regional 
Hospital (Norman, OK) in compliance with a University IRB approved protocol (Fig. 
5.3A). Cords were stored at +5°C for no more than 48 h post delivery. Before processing, 
the cords were washed with double-distilled water to remove the residual blood and cut at 
an initial length of 100 mm. The cords with an outer diameter of approximately 6 mm 
were used for the experiments. The cords were stretched on stainless steel mandrels (316 
stainless steel tube, 4 mm ID, 6 mm OD 200 mm L) (MicroGroup, Inc., Medway, MA) 
and secured at each end with plastic zip ties. Mounted cords were wrapped in paper 
towels and placed in a polystyrene canister to allow progressive freezing (1°C/min) to -
86°C.
227
 After a minimum of 48 h, vessels were removed from the -86°C freezer (Fig. 
5.3B), mounted into the lathe (Model 23M80D, MicroKinetics Corp., Kennesaw, GA) 
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(Fig. 5.3C), and machined to wall thicknesses of 0.4 and 0.8 mm with a tungsten carbide 
cutting tool (Fig. 5.3D). Dimensional control was programmed using TurnMaster Pro for 
Windows with a spindle speed of 2000 rpm, and ramp speed of 200 steps/sec. 
Immediately after dissection, tissue sections were stored at -20°C for 1-2 h (Fig. 5.3E), 
then transferred to a container filled with chilled distilled water at +5°C refrigeration for 
no more than 24 h to fully thaw. Prior to decellularization, vessels were removed from 
+5°C storage and maintained at room temperature for 1 h.
227













                
                                              




Figure 5.3. Preparation of the HUV scaffold. The human umbilical cords (HUCs) were obtained 
from the birth center (A), washed thoroughly to remove the blood and mounted on stainless steel 
mandrels. The cords were then frozen down to -86C (B). The cord is then placed in a computer-
controlled lathe (C), and the lathe is engaged with the cutting tool transversing the section (D). 
The dissection process yields a smooth surface having the desired tissue wall thickness (E). 
Thawed human umbilical vein (HUV) segment immediately after longitudinal dissection (F). 








5.2.2. Decellularization of HUV Tissue Sections 
Thawed HUV sections were cut longitudinally to generate flat sheets (Fig. 5.3F) and 
placed in glass bottles containing 1% sodium dodecyl sulfate (SDS) (Mallinckrodt Baker, 
Inc., Phillipsburg, NJ) in distilled water, and agitated under constant shaking (100 rpm) 
for 24 h. SDS was selected on the basis of being a widely used surfactant for 
decellularization processes with its ability to preserve scaffold integrity while removing 
immunogenic cellular components.
288, 291, 292
 The decellularization solution was decanted 
and the tissue samples were washed in distilled water (3x) to remove residual surfactant. 
Samples were then incubated overnight at room temperature in phosphate buffered saline 
(PBS) (Gibco Life Technologies, Grand Island, NY) containing 70 U/mL DNase I 
(Sigma-Aldrich Inc., St. Louis, MO) to digest the DNA. Subsequently tissue sheets were 
washed in PBS (3x) to remove residual DNase. Samples were terminally sterilized using 
0.2% peracetic acid /4% ethanol solution for 2 h, after which samples were pH balanced 
(pH 7.4) using multiple washes in PBS.
295, 312
 Peracetic acid solution was from Sigma 
Aldrich (St. Louis, MA). All decellularization solutions were sterile and the treatment 
steps were performed at room temperature (20-25ºC). The tissue/solvent ratio was kept as 
1/20 (w/v) for each step, unless otherwise stated.
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5.2.3. Biomechanical Analysis  
5.2.3.1 Uniaxial Tensile Testing. A uniaxial tensile testing rig (Instron Corp., 
Model 5542, Norwood, MA) equipped with a 500 N load cell was used for the stress-
strain analysis. Tissue strips (3  18 mm) were cut in both longitudinal and 
circumferential orientations using a template to maintain dimensional consistency. Wall 
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thickness of the tissue strips (cut at 400 µm and 800 µm initial wall thickness) were 
measured again with an electronic digital caliper (Starrett Co., Athold, MA) to ± 0.001 
mm accuracy after decellularization due to tissue swelling. New dimensions were used 
for tissue cross-sectional area measurements. Strips were subjected to tensile testing as 
described in Section 4.2.2.1.  
5.2.3.2. Stress Relaxation. The viscoelastic tissue response of HUV was assessed 
by stress relaxation analysis (Please refer to Section 4.2.2.2). 
5.2.3.3. Suture Holding Capacity. Suture holding capacity was assessed on HUV 
sections (9  18 mm) by applying uniaxial stress. A single sterile 3-0 braided silk suture 
(Henry Schein, Melville, NY) was passed through the center of one end of the tissue 
section 3 mm below the edge, with the other glued to sand paper and attached to the grip. 
Samples were preloaded and preconditioned (as above in tensile testing), and stretched at 
an extension rate of 5 mm/min until failure. 
5.2.4. In vitro Culture and Seeding of Human Gingival Fibroblasts (hGFs) 
Primary human gingival fibroblasts (hGFs) (American Type Culture Collection (ATCC), 
Manassas, VA) were cultured in 75-cm
2
 culture flasks under a humidified atmosphere of 
5% CO2 and 95% air at 37°C. Cells were maintained with Dulbecco’s Modified Eagle’s 
Medium (DMEM) (500 mL) supplemented with 10% animal serum complex (FetalPlex, 
Gemini Bio-Products, West Sacramento, CA), 1% 200 mM L-glutamine, 50 kU penicillin 
and 50 mg streptomycin (Gibco Life Technologies, Grand Island, NY). Media was 
replenished every 3 days. The cells were serially passaged when 80-90% confluent by 
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enzymatic digestion with Accutase (Innovative Cell Technologies, Inc., San Diego, CA) 
and expanded in the humidified incubator at 37°C with 5% CO2.  
Circular disks (16 mm in diameter) were punched from acellular HUV sheets (0.8 mm-
cut) using a stainless-steel hollow punch under sterile conditions. Tissue disks were then 
placed in 24-well tissue culture plates (BD Falcon, San Jose, CA) and before cell seeding, 
incubated in DMEM culture media containing 15% FBS overnight to enhance cell 
attachment.
314
 Cells were seeded independently on both the lumenal and ablumenal 




. Before seeding the cells on 
the scaffolds, the culture media was aspirated from the T75 culture flasks and cells were 
detached from the surface of T75 culture flasks with 5 mL of accutase for 15 min. Then 
an equivalent volume of culture media (5 mL) was added to the suspension to inactivate 
the enzyme. The suspensions were transferred to 15 mL falcon tubes and centrifuged at 
1100 rpm for 5 min. The solution was aspirated from the tubes and the cell pellet was 
resuspended in 10 mL of fresh culture media. Then 0.5 mL of this cell suspension was 
mixed with 0.5 mL Trypan Blue (Invitrogen Corp., Grand Island, NY) in an eppendorf 
tube, and the viable cells were counted using a haemocytometer. When the cell clumps 
appeared, the samples were vortexed to count the cells. The seeded scaffolds were 
statically cultured for 3, 6, 9, 15, 18, and 21 days, and assayed for metabolic activity and 
cell proliferation.  
5.2.5. DNA Quantification 
The DNA content of the cultured HUV scaffolds was evaluated using the Picogreen 
Assay kit (Molecular Probes, Eugene, OR). PicoGreen methodology was adopted due to 
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its high sensitivity to low levels of dsDNA, direct correlation with cellular proliferation 
and highly reproducible nature.
315, 316
 PicoGreen reagent effectively binds to ds-DNA, 
however sample preparation requires enzymatic digestion to release the DNA.
317
  
For each culture period (3, 6, 9, 15, 18, and 21 days), the DNA content was assessed to 
evaluate cell proliferation. Tissue disks were carefully washed with PBS to remove 
culture media, and then incubated in 1 mL of 200 U/mL DNA-free, sterile-filtered 
collagenase solution (Sigma-Aldrich Inc., St. Louis, MO) in PBS for approximately 2 
hours at 37°C to digest tissue. Cells were then lysed by three consecutive freeze-thaw 
cycles at -86°C to release DNA. The cell-containing solutions (100 L) were incubated 
with an equal volume of (100 L) diluted PicoGreen reagent (PicoGreen 
dimethylsulfoxide stock solution diluted 200 in TE assay buffer) in black bottom, 96-
well plates (Greiner).
318
 Samples to be assayed were incubated for 5 min protected from 
light at room temperature. The fluorescence was measured at an excitation wavelength of 
480 nm and an emission wavelength of 520 nm using a Synergy HT plate reader (Bio-





                                                                                         
 
Where, the DNA concentrations (g/mL) of the samples with unknown cell densities 
were calculated by extrapolating the Bacteriophage  DNA (Invitrogen) standard curve 
(Appendix A), and the DNA content per hGF was assumed as 6.61  1.2 pg DNA/cell.
320
 
(DNA content per cell) (pg/cell)  
Number of cells  =  
DNA concentration (g/mL)  volume (mL)  10
6




5.2.6. Assessment of Cellular Metabolic Activity 
Gross metabolic activity of seeded cells on lumenal and ablumenal surfaces of the HUV 
scaffold was assessed by quantifying the reduction of the non-toxic Alamar Blue (AB) 
reagent at the end of each culture period. The assay basically yields an 
oxidation/reduction reaction as the cells grow and lets the experimenter analyze the 
viability of the cells at the end.
321
 The AB assay in concert with direct measures of 
proliferation (DNA quantification) provides information on the metabolic state of the 
cells.
322
 Briefly, the culture media was aspirated from the wells, and 1 mL of fresh 
medium supplemented with 10% (v/v) AB reagent (Biosource International, Camarillo, 
CA) was added to each well. After 6 h of incubation, the 100 µL of solution was sampled 
from each well and transferred to 96-well plates (Costar). The absorbance was measured 
at wavelengths of 575 and 600 nm using a Synergy HT plate reader (Bio-Tek 
Instruments, Inc., Winooski, VT). Acellular tissue discs cultured with media without cells 
served as negative controls. Percentage AB reduction was calculated according to the 
manufacturer’s protocols by using Eqn (2): 
 
 Percentage reduction of Alamar Blue       
 
 
where, OX is the molar extinction coefficient of AB oxidized form (blue), RED is the 
molar extinction coefficient of AB reduced form (red). The molar extinction coefficients 
for the oxidized form (OX) at the wavelengths 570 (1) and 600 (2) nm are 80586 and 
(2) 


















=  100  
67 
 
117216, respectively. On the other hand, the molar extinction coefficients for the reduced 
form (RED) at the wavelengths 570 and 600 nm are 155677 and 14652, respectively. A 
denotes the absorbance of the test wells, and A’ represents the absorbance of the negative 
control wells.  
5.2.7. Scanning Electron Microscopy (SEM) Surface Analysis 
SEM analysis was conducted to qualitatively assess the surface morphology of the 
acellular HUV (for the 0.4 mm- and 0.8 mm-cut sections) and also to demonstrate hGF 
attachment and visualize cell morphology on the recellularized scaffolds (0.8 mm-cut 
sections). HUV tissue sheets were fixed in 1% (v/v) glutaraldehyde (Sigma, St. Louis, 
MO) for 4 h, then washed with PBS 3× for 5 minutes each. The samples were then 
treated with 1% (v/v) osmium in PBS for 2 h and washed with PBS 3× for 5 minutes 
each. The samples were then dehydrated in graded ethanol solutions (30%, 50%, 70%, 
90%, 95%, 100%, for 10 min each). The final step consisted of critical point-drying 
(Autosamdri-814, Tousimis, Rockville, MD), and gold sputtering (Model Hummer VI, 
Anatech Ltd., Hayward, CA) of the samples. Surface images were taken using a JEOL 
LSM-880 SEM at 15 kV. 
5.2.8. Histological Analysis Using Light Microscopy 
Histological analysis was performed to evaluate the effectiveness of the decellularization 
process, and then to observe the attachment and migration of hGF cells reseeded on the 
acellular HUV scaffolds (0.8 mm-cut). Please refer to Section 4.2.3. 
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 5.2.9. Visualization of the Fixed Cells with 4,6-diamidino-2-phenylindole (DAPI) 
Fluorescent Dye 
The hGFs attached on the ablumenal surface of the HUV scaffold (16 mm-diameter 
tissue disks) were visualized using a fluorescent nuclear stain that is excited by ultraviolet 
light, showing blue fluorescence when bound to DNA. Briefly, from a stock solution of 
4,6-diamidino-2-phenylindole (DAPI) (Invitrogen, Eugene, OR) (10 mg/ml in distilled 
water) was diluted 5000-fold in PBS. The culture media was aspirated from the wells of 
the culture plate containing seeded scaffolds (seeding density = 250,000 cells/disk) and 
the tissue sections were rinsed three times with PBS (5 minutes each).  Due to the light 
sensitive nature of DAPI dye, the staining should be performed in a dark venue. Samples 
were then fixed in a 3.7% formaldehyde solution for 20 minutes followed by 
permeabilization of the cells by immersion in 0.2 % Triton X-100 for 5 minutes. This 
solution was then aspirated and samples were rinsed in PBS for three times (5 minutes 
each). Samples were then incubated in the prepared DAPI labeling solution for 1-5 
minutes at room temperature. Samples were then rinsed in PBS three times (5 minutes 
each) and mounted. Observation of DAPI-labeled DNA was carried out with a Nikon 
Fluorescent microscope (Nikon Eclipse E800) and image analysis with MetaMorph 
software V6.2 from Molecular Devices. The excitation wavelength maximum is near 359 
nm and the emission wavelength maximum is approximately 461 nm when bound to 






Statistical analyses were performed using the SPSS 15.0 for Windows software (SPSS 
Inc., Chicago, IL, USA). The Student’s t-test was used to test for significant differences 
between two test groups. One-way univariate analysis of variance (ANOVA) was used to 
test for significant differences among multiple test groups. The Levene’s test for 
homogeneity was used to test for equal variance among samples. When equal variance 
could be assumed, the Tukey honestly significant difference (HSD) test was applied to 
perform post hoc comparisons among multiple test groups. Otherwise the post hoc 
analysis was done using the Games-Howell method. Statistical significance was set at p < 
0.05 for all tests. Analysis of cellular interactions with the HUV scaffold used a minimum 
of three separate cords (from different individuals) with a further three samples taken 
from each cord (with mean values of each triplicate set used to calculate statistical 
significance as n = 3). Due to increased mechanical variability between cords, a larger 
data set was used for mechanical analysis with a minimum of nine separate cords used in 
each set (n = 9). All values are expressed as mean ± standard deviation (SD). Results are 
presented as box plots, representing the mean  1 SD, with the dark line within each box 
representing the median value. Lines extending outside the box represent the data range 







5.3.1. Biomechanical Assessment  
5.3.1.1. Uniaxial Tensile Testing. Irrespective of initial tissue wall thickness (0.4 
mm- or 0.8 mm-thick), the longitudinal HUV sections exhibited significantly higher 
failure loads than circumferential sections (p < 0.001, n = 9). Representative stress-strain 
curves derived from the load-displacement data displayed characteristic behavior of soft 
biological tissues (Fig. 5.4).
323
 Data shows an initial toe region demonstrating the 
alignment of elastin fibers parallel to the stretching axis, followed by a linear region 







Figure 5.4. Representative stress-strain curves for the HUV samples. The longitudinal (L) strips 
demonstrated significantly higher stress values compared with the circumferential (C) strips for 
both 0.4 and 0.8 mm thicknesses.  
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One-way ANOVA revealed that the longitudinal strips demonstrated a significantly 
higher tensile strength than circumferential strips (p < 0.001). A statistically significant 
difference in Young’s modulus was also detected between the longitudinal and 
circumferential sections for both thicknesses (p < 0.005). Data obtained from tensile 
testing are summarized in Table 5.1. 
 






Mean and standard deviation
 
were calculated for each tensile property for a sample size of n = 9. 
Pairwise comparisons (statistical significance set at p < 0.05) are reported between the groups:  
versus 0.4 mm-L; § versus 0.8 mm-L; Ұ versus 0.4 mm-C; # versus 0.8 mm-C. 
 
SEM results showed the ablumenal surface of the 0.4 mm-cut samples (exposing the 
transitional area between the adventitia and Wharton’s Jelly proper) to have a relatively 
dense three dimensional fibrous network (Fig. 5.5A), compared to the 0.8 mm-cut 
sections, which was deeper into the Wharton’s Jelly, that displayed ECM fibers with a 
loose, wavy morphology (Fig. 5.5B). The basement membrane on the lumenal surface of 






Figure 5.5. Morphological observations of the ablumenal and lumenal surfaces of the acellular 
HUV scaffold using scanning electron microscopy. Observations show that the ablumenal surface 
of the HUV cut at 0.4 mm thickness (A) (×200) have densely arranged collagen fibers, whereas 
the 0.8-mm-cut samples (B) (×200) have the fibers that are more loosely arranged due to the 
heterogeneity of the extracellular matrix composition and collagen packing. The lumenal surface 
(C) (×200) shows a tightly packed extracellular matrix structure. The upper insets display a 





5.3.1.2. Stress Relaxation Analysis. Stress-relaxation curves show an initial rapid 
stress decay, followed by a gradual decrease over time. Equilibrium stress values, , 
were attained within 180 seconds of relaxation (Fig. 5.6).  
                      
 
Figure 5.6. Representative normalized stress relaxation curves (n = 9). The initial stress decays to 
an equilibrium stress over time. The stress-relaxation data showed the viscoelasticity of the 
longitudinal (L) HUV strips to be significantly higher than the circumferential (C) strips for both 
thicknesses (Tukey honestly significant difference, p < 0.05). Pairwise comparisons for 
normalized equilibrium stress (t = 180 s) (statistical significance set at p < 0.05) are indicated 




The degree of relaxation was greater for tissues in the longitudinal orientation compared 
with tissues in the circumferential orientation, suggesting the stress contribution of the 
viscous components (-) to the total stress () was higher (Table 5.2) (p < 0.05, n = 
9). As expected, the relaxation response indicates variation in the composition of the 
viscoelastic components within the HUV, and demonstrated a time-dependent stress 
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response. The results for the stress relaxation test on the acellular human umbilical vein 
(HUV) matrix were summarized in Table 5.2. 
 
TABLE 5.2. STRESS RELAXATION DATA FOR THE ACELLULAR HUMAN UMBILICAL VEIN (HUV)-
DERIVED SCAFFOLDS
*
     
 
*
 Mean and standard deviation were calculated for each relaxation data for a sample size of n = 9. 
Pairwise comparisons (statistical significance set at p < 0.05) are reported between the groups:  
versus 0.4 mm-L; § versus 0.8 mm-L; Ұ versus 0.4 mm-C; # versus 0.8 mm-C.  
 
 
5.3.1.3. Suture Holding Capacity. Suture retention was determined as the 
maximum load a single sterile 3-0 braided silk suture can withstand under uniaxial 
tension before failure (Fig. 5.7). The suture holding capacity of the 0.8 mm-cut, 
circumferential HUV strips (2.20  0.24 N) was significantly higher than the longitudinal 
strips for the same thickness (1.53  0.16 N) (p < 0.001, n = 9). However, there was no 
significant difference in the failure loads between longitudinal (1.38  0.21 N) and 
circumferential (1.52  0.27 N) orientations of the 0.4 mm-cut sections (p = 0.59). The 
0.8 mm-cut HUV sections demonstrated significantly higher suture holding capacity than 
75 
 
the 0.4 mm-cut sections in the circumferential direction (p < 0.001), whereas there was 
no significant difference between the two thicknesses in longitudinal orientation (p = 
0.58).  
   
Figure 5.7. Suture holding capacity. The 0.8-mm-cut HUV strips oriented longitudinally (L) 
showed significantly lower failure rates than the strips oriented in the circumferential (C) 
direction for the same thickness (after decellularization; Tukey honestly significant difference, p 
< 0.0001, n = 9). There was a significant difference in suture holding capacity between the 0.4-
mm-cut and 0.8-mm-cut HUV sections in circumferential orientation only (p < 0.001); all other 
data displayed no statistical difference. 
 
 
5.3.1.4. Mechanical Property Comparison Between the HUV Graft and the 
Porcine Oral Soft Tissues. A comparative analysis between the mechanical properties of 
the HUV and the porcine oral soft tissues was performed to draw a conclusion on the 
details of HUV’s biomechanical properties as a periodontal graft. The mechanical 
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properties of the longitudinal HUV sections cut at 0.4 mm were considered for the 
comparative analysis since HUV demonstrated the highest tensile strength and 
viscoelasticity at this initial wall thickness and orientation. One-way ANOVA indicated 
the ultimate strength of longitudinal HUV strip (0.4 mm-cut) was significantly higher 
than the porcine buccal mucosa (Games-Howell, n = 9, p < 0.001), and significantly 
lower than the porcine attached gingiva in both lingual and buccal aspects (p < 0.05).  
However, there was no significant difference between the HUV and the lingual and 
buccal alveolar mucosal sections (Fig. 5.8).  
     
 
 
Figure 5.8. Ultimate strength. HUV, human umbilical vein (0.4 mm-L); LAG, lingual attached 
gingiva; BAG, buccal attached gingiva; LAM, lingual alveolar mucosa; BAM, buccal alveolar 
mucosa; BM, buccal mucosa. Values indicate mean  standard deviation (n = 6). The symbol 
*
 
denotes statistically significant difference set at the 0.05 level. Only the comparison between the 







One-way ANOVA revealed that the Young’s modulus value of the HUV strip 
(longitudinal, 0.4 mm-cut) was significantly higher than the tissue strips extracted from 
the porcine lingual and buccal alveolar mucosa and the buccal mucosa (Games-Howell, n 
= 9, p < 0.001). However, the stiffness of the HUV was insignificantly different from the 
lingual and buccal attached gingiva.  
The stress relaxation analysis demonstrated the HUV was significantly more viscoelastic 
than the porcine lingual and buccal attached gingiva and buccal mucosa (Tukey, n = 9, p 
< 0.005). The viscoelasticity values of the HUV and the porcine alveolar mucosal tissues 
were insignificantly different from each other (Fig. 5.9). Viscoelasticity was assessed 
from the ratio of the stress contribution of the viscous components (-) to the total 













    
Figure 5.9. Viscoelasticity. HUV, human umbilical vein (0.4 mm-L); LAG, lingual attached 
gingiva; BAG, buccal attached gingiva; LAM, lingual alveolar mucosa; BAM, buccal alveolar 
mucosa; BM, buccal mucosa. Values indicate mean  standard deviation (n = 6). The symbol 
*
 
denotes statistically significant difference set at the 0.05 level. Only the comparison between the 
HUV and different regions of porcine tissue has been made.  
 
 
5.3.2. Cell Growth and Metabolic Activity in Scaffolds 
After an initial latency period of 9 days, hGFs started proliferating irrespective of the 
surface on which they were seeded (Fig. 5.10). However, increased proliferation of cells 
seeded on the ablumenal surface resulted in a cell density significantly higher (77000  
3000 cells/disk) compared to cells cultured on the lumenal surface (42000  4000 






       
Figure 5.10. Proliferation of human gingival fibroblasts (hGFs) over time. Cell density was 
significantly higher for the ablumenal surface at days 15, 18, and 21, reflecting a higher cell 
proliferation on this surface (Student’s t-test, p < 0.001, n = 3). 
 
 
The metabolic activity of cells cultured on the ablumenal surface was significantly higher 
(per cell) than cells cultured on the lumenal surface, indicating cellular metabolism was 
influenced by the material’s surface structure/composition and higher surface area of the 




    
Figure 5.11. Metabolic activity of hGFs seeded on the HUV scaffold. By the end of 21-day 
culture period, Alamar Blue reduction (%) per cell for the ablumenal surface was significantly 
higher than cells seeded on the lumenal surface, demonstrating that hGFs metabolic activity was 
influenced by the material’s surface structure/composition (Student’s t-test, p < 0.05, n = 3). 
Penetration into the tissue through the ablumenal surface could account for this difference (see 
histology, Figs. 5.12B and 5.12C). 
 
 
The complete removal of cellular material from the HUV matrix after decellularization 
was confirmed by H&E staining (Fig. 5.12A). Histology verified the adhesion of hGFs on 
both lumenal and ablumenal surfaces, however cell migration was only observed from 
the ablumenal surface (Fig. 5.12B). Cells cultured on the lumenal surface did not 
penetrate the basement membrane and remained on the surface of the scaffold after 21 
days in culture (Fig. 5.12C). 
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Figure 5.12. Histologic images of hematoxylin and eosin (H&E)-stained HUV sections (0.8 mm-
cut) before cell seeding (A) and after cell seeding on ablumenal (B) and lumenal surface (C). The 
images show that the decellularization removed all the cellular components, and the hGFs have 
tendency to adhere both surfaces, but migrate into the scaffold only through the ablumenal side. 
Arrows indicate the side onto which the cells were seeded.  
 
 
 The DAPI staining also confirmed the attachment of the hGFs on the ablumenal surface 
of the HUV scaffold (Fig. 5.13A) with the control plastic surface (Fig. 5.13B).  
 
         
Figure 5.13. Fluorescent microscope images of human gingival fibroblasts (hGFs) seeded on the 
ablumenal surface of HUV (A), and the plastic control surface (B).  
 





The goal of periodontal tissue engineering is to create a 3D scaffold material that is 
immunologically compliant, improves cellular integration and remodeling while 
withstanding physiological loading stresses. While the details of human tissue from the 
gingival and surrounding tissues are yet to be fully defined, a human derived ECM of 
similar dimension to the periodontal tissues, such as the HUV, may have these desired 
properties. It is envisioned that when implanted with its relatively porous ablumenal 
surface against the wound site, HUV can provide the necessary environmental signals, 
such as adhesion molecules, and more natural ECM biomechanics, at least compared to 
rigid synthetic alternatives, for gingival wound healing to occur. The relatively less 
porous lumenal surface would be implanted facing the oral cavity, with the aim of 
preventing the penetration of epithelial cells which would inhibit the regenerative healing 
process. As a potential barrier implant with directional inhibition of cellular migration, 
the HUV has important implications from a wound healing perspective. Ideally, cells 
interacting with the ablumenal surface of the HUV (at the wound interface) may have 
more time to repair damaged tissues before the negative influences of other invading cell 
types limit repair. Although not assessed in these investigations, the HUV may also 
mitigate bacterial invasion from the oral cavity through similar mechanisms to eukaryotic 
cells, and thus limit infection and inflammation at the wound site. 
The HUV has potential as a biocompatible material for periodontal tissue regeneration, 
and as such, it is essential that the material’s biomechanical properties and cellular 
interactions be evaluated prior to in vivo testing. However, published data on the 
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mechanical properties of the HUV is minimal, and requires additional analysis in order to 
draw appropriate comparisons between the HUV and other surgical barriers. Barriers 
such as Alloderm and Biomend have been reviewed and their mechanical properties 
evaluated previously.
328, 329
 Hoenicka et al.
330
 investigated the tensile properties of HUV 
ringlets with their findings supporting a biphasic and anisotropic behavior. This data was 
consistent with the findings of Pennati,
222
 who reported the anisotropy of HUV while 
assessing the stress-strain relationship of Wharton’s Jelly, longitudinal HUV strips, and 
circumferential HUV ringlets. An important distinction between this work and previous 
investigations assessing vessel mechanics has been the use of tissue strips rather than a 
mixture of ringlets and strips for the circumferential and axial directions. Typically, with 
smaller vessels, ringlets have been used for analysis of circumferential properties due to 
limitations in sample size, and strips in the axial direction where sample length is less of 
an issue. By using strips in both orientations, a more accurate comparative analysis that 
provides details on fiber structure can be conducted. These investigations have shown the 
tissues tensile characteristics to have an anisotropic response, with stress-strain behavior 
differing between longitudinal and circumferential orientations. The greater tensile 
strength of the longitudinally-oriented samples may be attributed to medial collagen 
fibers aligned in the axial direction, rendering an orthotropic mechanical behavior. This 
parallel alignment also increases material stiffness resulting in a higher resistance to 
tensile loading.
324, 331, 332
 The smooth muscle cell alignment within the medial layer was 
assumed to correlate well with the collagen fiber orientation in this layer.
333
 With tissue 
strips oriented in the circumferential direction, the bulk collagen fibers are aligned 
perpendicular to the loading axis. As load is applied, the fibers begin to realign parallel to 
84 
 
the stretching axis, and the degree to which this realignment occurs determines the load 
bearing capacity.
223, 334
 When the fiber alignment was perpendicular to the load, these 
strips demonstrated lower mechanical strength.
335
 Similarly, the 0.8 mm-cut tissue 
sections consisting more of the Wharton’s Jelly retained sutures to a higher stress value in 
the circumferential direction where the fiber orientation was perpendicular to the axial 
stress.   
Tensile properties of the HUV machined to a wall thickness of 0.4 and 0.8 mm 
demonstrated gradients in stress-strain behavior through the scaffold wall, consistent with 
a material of heterogeneous composition (Fig. 5.4). The medial layer exhibited higher 
uniaxial tensile strength and anisotropy and showed a more dense fiber structure 
predominantly aligned in the axial direction. Conversely, the tissue layer surrounding the 
media (Wharton’s Jelly) was shown to have a lower strength, associated with a randomly 
organized, less dense fiber structure. Unlike veins, the medial fiber orientation in arteries 
was reported to be in the circumferential direction.
336
  
Stress-relaxation analysis was used to determine the viscoelastic properties of HUV.
334
 
The initial strain energy is driven by the internal rearrangement of the collagen fiber 
network, which then gradually diminishes as the stress relaxes.
337
 The greater the 
difference between initial and equilibrium stress values, the lesser the degree of tissue 
deformation and higher the potential of the tissue to recover toward its initial fiber 




Elastin has been reported to have minimal relaxation with a high elasticity, whereas 
collagen and smooth muscle are relatively stiffer but exhibit greater relaxation.
226
 
Possible mechanisms responsible for the HUV stress-relaxation properties include, the 
time-dependent reorientation of the fibrous proteins through the viscous matrix, the 
relaxation of the non-fibrous ECM components, or the time-dependent interactions 
between the fibrous and non-fibrous components.
337
 The circumferential HUV strips 
were less viscoelastic, whereas the longitudinal tissue sections showed a more rapid 
stress-relaxation decay, demonstrating a greater viscoelastic behavior. This result can be 
attributed to the collagen fibers and smooth muscle layers within the medial layer that are 
the primary factors influencing the materials viscoelasticity. Material properties of the 
HUV have demonstrated characteristic features of soft biological connective tissues with 
a nonlinear stress-strain relationship, a decreasing hysteresis loop in preconditioning 
(data not shown), and stress relaxation at constant strain.
226
 These results show that both 
the composition and layered architecture of the decellularized HUV plays a significant 
role in the materials biomechanical and biological properties.  
The adhesion, growth, and proliferation of human gingival fibroblasts (hGFs) on the 
HUV biomatrix were examined to assess characteristics of the lumenal and ablumenal 
surfaces that may influence cell behavior. Cells adhered on both surfaces of the scaffold, 
and after a lag phase of 9 days, started proliferating within the scaffold. The penetration 
of cells into the 3D scaffold was, however, only observed through the ablumenal surface. 
The extended lag phase is likely a specific response of these human derived primary cells 
as cultures on tissue culture plastic displayed a similar proliferation profile. The relatively 
long lag phase, with fewer attached cells than the initial seeding density to modify the 
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scaffold, may also explain why the total cell density was lower than might have been 
expected by the end of the 21 day culture period.  
The bimodal cell migration characteristics, where cells on the lumenal surface were 
unable to penetrate the basement membrane maybe attributed to the more densely packed 
morphology of the extracellular matrix (ECM). In addition, components such as elastin 
that may inhibit migration by being more resistive to cell secreted matrix remodeling 
enzymes. By comparison, ECM components on the ablumenal surface are more loosely 
arranged with large void spaces. These results were supported by assays quantifying 
cellular metabolic activity and proliferation rates where the more porous structure of the 
ablumenal surface, composed predominantly of Wharton’s Jelly, enhanced the migration 
of hGFs into the matrix. However, a quantitative analysis of the porosity of the HUV-
derived scaffold as well as studies that assess cell migration and ECM remodeling over 
longer time frames are yet to be done.  
5.5. CONCLUSIONS 
In these investigations, we have developed a unique scaffold that may have promise as a 
biofunctional matrix for periodontal and other regenerative surgical procedures. Results 
have shown the potential of the HUV bioscaffold to serve as a strong, elastic tissue 
matrix. We have demonstrated the processed HUV-derived ECM graft to have in vitro 
biocompatibility, with desired natural tissue matrix characteristics that acts as a selective 
barrier while enhancing cell growth, as well as having favorable mechanical 
characteristics. As such, the HUV bioscaffold offers a promising approach that utilizes 
the natural structure of the vascular wall to modulate cellular interactions. By allowing 
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cells to adhere to the lumenal surface (at the oral cavity interface), but limit their apical 
migration, an extended period for natural wound healing responses will be available to 
regenerate these underlying tissues. In addition, the material’s bimodal cell migration 
characteristics may be taken advantage of in a number of surgical applications that 
require cell barriers. Further analysis of these interactions may improve our 
understanding of the mechanisms that drive cell migration and wound healing responses. 
In addition, the unique features of a vascular-derived material that functions as a 
resorbable barrier scaffold may have a number of reconstructive and regenerative 


















BIOREACTOR DESIGN CONSIDERATIONS FOR 




Tissue engineering aims to develop scaffolding materials under the mechanical (shear, 
tension, compression, etc.), biological and physicochemical (pO2, pH, pCO2, glucose, 
etc.) conditions that are similar to in vivo conditions. Bioreactors are therefore important 
tools for achieving this specific goal. The operating parameters within the bioreactor 
system should be controllable in order to manufacture tissue constructs that could meet 
the market demand in terms of performance, uniformity, reproducibility and 
scalability.
338
 Therefore, emerging technologies, such as biosensors, are utilized to 
control the varying composition of these vital components.
339
 Mass transport of the 
nutrient supply, gases and waste products should also be considered while designing a 
bioreactor system. The above-mentioned factors are closely interconnected and should be 
considered together to design a bioreactor system that simulates the physiological 





6.1.1. Mechanical Stresses  
Perfusion culture systems are used for the cultivation of engineered constructs due to 
their superior effects on the scaffolds compared to the static cultures.
340
 While perfusing 
media through the bioreactor system, the nature and magnitude of the mechanical stresses 
applied have a direct and profound influence on the biomaterial. The tissue constructs 
under mechanical stimulation demonstrate changes in their biological responses, 
mechanical properties, and matrix composition.
341-343
 Therefore, the role of the 
mechanical forces within a bioreactor system is very important as it determines the final 
tissue characteristics by the end of culture period. 
The nature of the applied mechanical force on human gingival fibroblasts (hGFs) has a 
tremendous effect on cellular attachment, proliferation and expression of specific 
regulatory genes.
344-346
 Theilig et al. (2001) studied the influence of gravitational force on 
cultured hGFs and reported an enhanced tenascin expression by the hGFs due to applied 
stresses.
347
 In another study, it has been concluded that the expression levels for the 
mRNAs encoding for the matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of 
metalloproteinases-2 (TIMP-2) were higher in human gingival fibroblasts (hGFs) 








However, a few studies have been reported in literature regarding the culture of hGFs in 
dynamic flow conditions.
349, 350
 One of the leading reasons behind this is that the current 
literature is deplete of studies regarding the quantification of the mechanical stresses 
acting in the oral environment. Jozef Kokini and co-workers estimated the shear stress on 
the tip of the tonque using the transport phenomena principles for the fluids in the 
mouth.
351-353
 Shama and Sherman (1973), estimated the range of shear rates acting in the 
mouth as 10-1000 s
-1
 depending on the type of fluid/food.
202
    
6.1.2. Gas Concentrations 
Variation in oxygen concentration has a significant influence on the development of 
tissue-engineered constructs.
354
 The hyperoxic conditions (high O2 tension) are known to 
stimulate the synthesis of tissue inhibitors against collagenase activity, induce the 
production of collagen, and thus increase the wound tensile strength, and cause an 
increase in glucose consumption rate by the wound cells.
355, 356
 On the other hand, 
hypoxia, i.e., low O2 tension, regulates the synthesis of specific genes by different cell 
types.
357-359
 The hypoxic conditions have been previously reported to have a stimulatory 
effect on various types of cells to synthesize vascular endothelial growth factor (VEGF), 
an important modulator for vascularization during wound healing.
360
 Hypoxia is also 
known to have an inhibitory action on angiogenesis.
361
  
While operation of the bioreactor systems for the cultivation of the tissue constructs, the 
rate of oxygen consumption of the cells within the scaffolds should periodically be 
monitored, as oxygen is usually the limiting factor in a bioreactor system due to its low 





In a periodontal wound healing environment, the defect site experiences low oxygen 
tensions due to the poor vasculature carrying 02 to the wound tissue, and the supply of 
oxygen towards this region promotes soft tissue wound healing processes.
354, 363
 
Therefore, in designing such systems mimicking the periodontal wound healing 
environment, one should consider keeping the oxygen concentration on the healing side 
relatively low (hypoxic).  
The carbon dioxide (CO2) concentration has been reported to vary during the periodontal 
wound healing processes, and this change in the CO2 tension also creates changes in the 
pH values.
364, 365
 The pH of the circulating media within the bioreactor system needs to 
be kept around 7-7.4, as the acidic culture conditions prevent the synthesis of newly-
formed ECM structures.
366
 Continuous replacement of the culture media with the 
perfusion flow helps maintaining the pH at its desired level, as due to the cellular 
metabolism, pH decreases.  
6.1.3. Fluid Composition  
The literature is scarce with regard to the fluid compositions in a periodontal wound 
healing environment. Similar to the gas concentrations, the periodontal wound fluid 
composition is also prone to change continuously through the healing cascade. Especially 
during the early stages of wound healing, blood clot formation occurs on the wound site. 
The blot clot mainly consists of cellular components, particularly red and white blood 
cells and platelets, in a matrix of fibrin, vitronectin, plasma fibronectin, and so forth.
367
 






6.2. MATERIALS AND METHODS 
6.2.1. Scaffold Preparation  
Human umbilical cords collected from the Delivery Suite of the Norman Regional 
Hospital were washed thoroughly with tap water to remove residual blood and cut at an 
initial length of 160 mm. The twisted cords were excluded from the study. Vessels were 
dissected according to an automated dissection protocol to 0.5 mm initial wall-thickness. 
The 0.5 mm initial wall thickness was the smallest attainable thickness which 
demonstrated the least variation in tissue thickness after thawing process. Relatively 
small tissue thickness was also preferred to minimize the variation in diffusion resistance 
values for the O2, nutrient and waste through the HUV scaffold during culture. The 
thinner scaffold also gives a lower rate of O2 consumption rate per unit volume of tissue 
construct depending on the density of the hGFs repopulating the scaffold. Please refer to 
Section 5.2.1 for the details of the scaffold preparation process. 
6.2.2. Decellularization of the HUV Scaffold 
After refrigeration in chilled distilled water, HUV’s were cut longitudinally to generate 
flat sheets (18 × 160 mm) and decellularized according to our optimized protocol 
(Please refer to Section 5.2.2) with the exception of DNAse I treatment for 4 h.   
6.2.3. Culture of Human Gingival Fibroblasts (hGFs) 
Primary human gingival fibroblasts (hGFs) were obtained from a patient and cultured as 
explained in Section 5.2.4. When the cells grown on 75 cm
2
 culture flasks reached to 
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approximately 70% confluency, they were recovered by acutase and subcultured. The 





6.2.4. Bioreactor Design Considerations 
The bioreactor system was designed while considering the physiological conditions 
during periodontal wound healing. In surgical practice, the HUV graft is implanted 
between the overlying gingival flap and the wound space. The graft is in contact with 
three different zones (regions) on the wound site, namely, the tooth surface (Region 1), 
wound space including the blood clot (Region 2), and the alveolar bone interface (Region 
3) (Fig. 6.1). The HUV graft is simply sandwiched between these three different regions 
and the gingival flap interacting with the oral cavity. Therefore, we designed and 
fabricated a modified parallel-plate flow bioreactor, where the HUV graft is placed 
between two flow compartments simulating the conditions in the oral cavity and wound 





     












Figure 6.1. Bioreactor design mimicking the periodontal wound healing environment. Region 1 
(Entrance): Tooth interface, Region 2 (Central): Blood clot zone, Region 3 (Exit): Alveolar bone 
interface.      
 
 
Each bioreactor assembly was made of acrylic plastic. The two flow compartments of the 
bioreactor were attached together with stainless-steel screws and silicone closed cell 
foam gasket (1.57 mm thick, Rogers Corp., Carol Stream, IL) was placed between the 
two parts. The assembly was connected to the perfusion flow with three-way stopcocks 






     
      
                                    
 
Figure 6.2. The top view for the top chamber of the bioreactor assembly (A), with the HUV 
membrane inserted in its place (B). The two flow compartments were attached with stainless steel 
screws (C), and the flow is maintained on both sides of the bioreactor; view for the bottom 
chamber (D) and the top chamber (E).   
 
 
The  pulsatile flow bioreactor system consisted of bioreactor assemblies, 2 peristaltic 
pumps (Masterflex L/S digital standard drive (model 7523-70) with L/S 4-channel pump 






reservoirs (diameter = 4.5 cm, height = 12 cm, 125 mL capacity each), silicon tubing, air 
filters (for the oxygenation of the medium reservoirs), polypropylene-based PharMed 
tubing (Cole-Parmer) and luer connectors (Value Plastics, Inc., Fort Collins, CO) (Figs. 
6.3 and 6.4). Zip ties were used to tighten the connections between the tubing and the luer 
connector. The whole bioreactor system was situated in an incubator at 37°C and 5% 








Figure 6.3. Schematic representation for the perfusion bioreactor system. Two peristaltic pumps 















The bioreactor system is presented in Fig. 6.4, where the three bioreactors maintain 
dynamic continuous flow conditions whereas the fourth bioreactor (top) serves as the 
quasi-static culture bioreactor. For the quasi-static conditions (i.e., low flow), the 
bioreactor was subjected to the same dynamic flow conditions for 3 hours every day, and 
the flow was stopped for this bioreactor. The three-way stopcock valves were used to 




             
 
Figure 6.4. (A) The perfusion bioreactor system used for the cultivation of the HUV bioscaffolds. 
The whole bioreactor system consists of four bioreactors connected in parallel arrangement. The 
top bioreactor maintains the quasi-static culture of the grafts. The media was changed every three 




6.2.4.1. Flow Conditions 
Literature is still scarce regarding the quantification of the mechanical forces acting on 
the periodontal soft tissues and the wound site. In the case of flow, the effective forces 
acting in the oral cavity are shear and extensional forces.
369





mechanical forces that could act on the HUV-derived membrane for periodontal GTR 
applications is difficult. In a surgical application, ideally, the HUV membrane will be 
completely covered with the gingival flap and the direct exposure of the graft to the oral 
environment conditions will be eliminated (See Fig. 6.1).  
The flow rate of saliva in the oral cavity is subjected to continuous change due to the type 
of stimulation.
370
 The unpredictability of the saliva flow rates in the oral environment, 
and the indirect contact of the HUV membrane with the oral environment due to its 
complete insertion beneath the flap, presented a challenge to predict the mechanical 
stresses that could be exerted on the implanted HUV scaffold from the oral cavity. To 
emulate the nearly stagnant fluid conditions within the wound space, fluid flow within the 
bioreactor section mimicking the wound space was kept very low as  0.9 mL/min = 
0.015 mL/sec, which is the corresponding speed of the pumps lowest attainable pulsating 
rate of 2 rpm (pulsating frequency of 0.13 Hz).  
Different pump settings were selected for the two sides of the bioreactor to adjust the 
flow rate. The tubing size was kept the same for the two chamber flow as 3.175 mm 
inside diameter (VWR, Suwanee, GA). The total medium volume circulating through the 
bioreactor system is 268.37 mL and 270.35 mL for the top and bottom chambers, 
respectively.  
A photograph and a schematic drawing for the bioreactor assembly are shown in Fig. 6.5. 
The height of the flowing fluid in the top chamber was denoted as h, the length of the 
flow with L, the width as b. The human umbilical vein (HUV)-derived scaffold is placed 




   
 
           
         
Figure 6.5. Photograph and schematic drawing of the bioreactor assembly used in the study. The 
bioreactor consisted of two flow compartments mimicking the periodontal wound environment. 
The top chamber has a fluid flow length of 105 mm, whereas the bottom chamber has the length 
of 35 mm. The fluid height for the top and bottom sides of the bioreactor are 1 and 6 mm, 




The wall shear stress, w (dyne/cm
2
) in the top chamber (Fig. 6.5) was calculated 
according to Eqn (3): 
                                      w                
where µ represents the dynamic viscosity of the culture media in dyne-s/cm
2
, Q is the 











height of the fluid flowing in the top chamber, in cm. The dynamic viscosity of the 






 The width, b, and the height, h, of the top 
chamber were 12 and 1 mm, respectively. The width-to-height ratio (b/h) for the top 
chamber of the bioreactor assembly was 12, which was greater than 1 demonstrating that 




The flow regime on the top chamber was examined by calculating the Reynolds Number 





; height of the fluid gap, h, of 1 mm; dynamic viscosity of the culture media, 






:    
                                       Re  =      
 
In the case of fully-developed flow, the entry length for the top chamber was calculated 
using Eqn (5): 
                                          Le    0.05 (h) (Re) 
 
Table 6.1 tabulates the wall shear stress, Reynolds Number (Re) and entry length (Le) 














TABLE 6.1. WALL SHEAR STRESS (W), REYNOLDS NUMBER (RE) AND ENTRY LENGTH (Le) 




























7.5 0.047 0.329 2.798 0.139 
10 0.062 0.434 3.690 0.184 
12.5 0.075 0.525 4.464 0.223 
15 0.088 0.616 5.238 0.262 
17.5 0.103 0.721 6.131 0.306 
20 0.12 0.84 7.143 0.357 
 
*
 average of triplicate measurements (n = 3).  
 
 
The calculated Reynolds numbers for different flow rates within the top chamber of the 
bioreactor were very low indicative of laminar flow. Due to the pulsating nature of the 
pumps, the flow was unsteady.
372
 The fluid flow rate for the top chamber was chosen as 
0.088 mL/s, driven by the four-roller pump at a rate of 15 rpm and a pulse repetition 
frequency of 1 Hz which was consistent with the chewing frequency of human.
375, 376
 The 
entry length for this flow rate was 0.262 mm, or 0.25% of the total length. The tissue 





6.2.4.2. Permeability of HUV Membrane 
The permeability of the oral mucosal tissues has been investigated in literature due to 
their potential use in drug absorption studies.
377, 378
 In vitro methods revealed that the 




In our modified parallel plate flow bioreactor system, the culture medium flows along 
and across the HUV membrane, thus creating both shear stresses and transmural 
pressure.
380
 Transmural pressure has been reported to tangentially strain the vessel walls 
and alter the tissue permeability, therefore different transmural pressures were tested on 
the HUV membrane.
381
 The fluid pressures on both sides of the bioreactor were measured 
using the Edwards TruWave Disposable Pressure Transducers (Edwards Lifesciences, 
Irvine, CA) connected to the four-channel biopotential amplifier of a sonomicrometry 
system (Sonometrics Corporation, Ontario, Canada) (Fig. 6.6). The instrument was 
calibrated before recording any pressure readings using the transducers. The system 
consisted of the Sonometrics’ Data Acquisition Computer and Sonometrics 4 Channel 
BioPotential Amplifier. SonoSoft v.3.4.45 software was used for the data acquisition and 




         
 
Figure 6.6. Sonomicrometry system (A). Pressure transducers (B) were connected to the flow 
through the luer connectors of the bioreactor assembly to monitor the pressure within the top and 




The pressure readings for the inlets and outlets of the top and bottom chambers were 
recorded after 25-30 min when the steady-state was reached for each pump pulsating rate, 
and the average transmural pressure (mmHg) across the membrane within the bioreactor 
was calculated using Eqn (6):  
 
                                                                                            
 
The transmural flow rate (Qf) for the tested top flow chamber flow rates were calculated 
by simply measuring the decrease in fluid amount (mL) in the media reservoirs feeding 
the top chamber with time. The average transmural pressure (TMPa) values and the 
corresponding Qf values for different pump speeds were listed in Table 6.2.    
(PTop, inlet – PBottom, inlet) + (PTop, outlet – PBottom, outlet) 
A B 




TABLE 6.2. AVERAGE TRANSMURAL PRESSURE (TMPa) AND TRANSMURAL FLOW RATE (Qf) 















5.038  0.126 
 
0.032  0.013 
7.5 6.103  0.388 0.055  0.009 
10 7.934  0.403 0.066  0.011 
12.5 8.713  0.665 0.088  0.006 
15 9.845  0.419 0.111  0.012 
17.5 11.327  0.481 0.122  0.011 
20 12.396  0.206 0.153  0.009 
 
*
 values expressed as mean  standard deviation of triplicate measurements (n = 3).  
 
 
In order to calculate the permeability of the HUV membrane, the Qf values were plotted 
against the TPMa values. Fig 6.7 depicts the interaction between the transmural flow rates 
and the transmural pressures across the HUV membrane.  
 
 










Figure 6.7. Transmural flow rate (Qf) as a function of average transmural pressure (TMPa) across 











                                        Q = Lp (bL) TMP                                                                          (7)   
 
where Lp is the hydraulic permeability of the porous lower ablumenal side of the HUV 
membrane; b is the width of the flow channel, 12 mm; L is the length of the flow channel, 
35 mm. The Lp was calculated from the simultaneous measurements of the Q and TMP 








6.2.4.3. Fluid Composition   
During wound healing, the wound space of the periodontal defect contains the blood clot 
and the growth factors accumulated in that region. The blood clot residing within the 
wound site will provide the necessary proteins to initiate and accelerate the healing 
processes. Therefore, the bottom chamber mimicking the protein concentrated wound site 
was circulated with culture media having relatively high serum (FBS) content (10%), 
whereas the top chamber mimicking the oral environment was perfused with media 
containing 1% FBS (serum). Izumi et al.
382
 studied the behavior of keratinocytes within 
oral mucosal substitutes with media having variable serum content and, interestingly, 
showed the cellular growth was not affected by the absence of serum in the media. In 
situations where the gingival flap is not sufficient to completely cover the GTR 
membrane placed underneath, the membrane could be in contact with saliva in the oral 
environment. The saliva protein concentration is known to be very low as 0.5 g/dL,
383
 




Glucose concentrations on both sides of the bioreactor were also kept different. Culture 
media without glucose was circulated on the side of the bioreactor mimicking the wound 
site, whereas the side of the bioreactor mimicking the oral cavity side was fed with media 
having low glucose concentration (1 g/L). As a result, a gradient in glucose concentration 
(driving stimulus) was created to further facilitate the migration of the hGFs seeded on 
the ablumenal side (facing the wound site) toward the lumenal surface.  
107 
 
6.2.5. Seeding of Tissue Constructs and Culture of Human Gingival Fibroblasts 
(hGFs)  
Decellularized HUV flat tissue sheets were fixed with sterile 3-0 silk black braided suture 
(Ethicon, Inc., Somerville, NJ) around a stainless-steel frame and cultured in sterile 150-
mm diameter petri dishes (VWR International, Sugar Land, TX). The scaffolds were 
incubated with the ablumenal surface facing up in culture media containing 15% FBS 
overnight to facilitate the initial attachment of the human gingival fibroblasts (hGFs) onto 
the scaffold. The potential of HUV as a GTR membrane has been reported in our 
previous study, where the results revealed that the hGF penetration was only observed 
through the ablumenal surface of the HUV membrane.
29
 This finding was probably due to 
the presence of Wharton’s Jelly on the ablumenal surface of the scaffold which has a 
relatively more porous, less-densely arranged fibrous structure and consists of the 
essential molecules, i.e., growth factors, signaling factors, etc. facilitating the attachment, 
growth, and proliferation of the hGFs.
294
 Therefore, in this study, the repopulation of the 
HUV graft by the human gingival fibroblasts (hGFs), and the subsequent healing via 
tissue ingrowth was expected to occur predominantly within the tissue region closer to 
the ablumenal surface of the HUV graft.
385
 A lamina propria-like tissue layer formation is 
high likely to be created on this side of the scaffold for prolonged culture times.
386, 387
  
Fibroblasts were then seeded on the ablumenal surface of HUV matrices at a seeding 
density of 1 × 10
6 
cells/cm², a relatively high seeding density to ensure there are enough 
matrix-secreting cells in the scaffolds. First, 7 mL of the cell suspension was dripped on 
each membrane and after 4 h of incubation, 30 mL medium was added to each petri dish. 
108 
 
The seeded scaffolds were incubated statically under a humidified atmosphere of 5% CO2 
and 95% air (Model Hera Cell 150, Thermo Scientific Heraeus, Waltham, MA) at 37°C. 
The media was changed 24 h after seeding to remove the debris, and then static culture 
was performed for 7 days to ensure adequate cell attachment prior to dynamic culture. 
The media was replenished every 3 days. By the end of the 7 day static culture period (t = 
0), the scaffolds in petri-dishes were transferred to the bioreactor assemblies situated in 
another incubator (Shel Lab Incubator Systems, Sheldon Manufacturing, Inc., Cornelius, 
OR). The HUV scaffolds were cultured under dynamic (flow) conditions within the 
perfusion bioreactor system for 7 days (t = 7) and 28 days (t = 28). No glucose media and 
low glucose media were circulated through the bottom (wound site) and top chambers 
(oral environment), respectively. Static cultures, including the control (acellular) and 
seeded scaffolds, were performed with the standard culture medium, and the media was 
replenished every 3 days (40 mL culture media per petri-dish).   
The bioreactor system components were sterilized with ethylene oxide while the medium 
reservoirs were autoclaved. Prior to ethylene oxide sterilization, silicone and PharMed 
tubing were cleaned in a solution of hot water and mild surgical soap, and then rinsed 
thoroughly in running distilled water. The tubing was sterilized after the interior surface 
becomes dry. The Petri dishes were wrapped with micropore tape (3M Company, St. 
Paul, MN). Contact surface areas between the flow and the HUV scaffold were 105  12 





6.2.6. Metabolic Activity of Cultured hGFs 
Metabolic activity of hGFs cultured on the HUV scaffold was assessed by the end of each 
culture period (t = 0, t = 7 days, and t = 28 days) using the Alamar Blue assay. At each 
time point, 5-mm diameter tissue disks (n = 3) were cut from the three different zones of 
the HUV scaffold and placed in white/clear bottom 24-well plates (BD Biosciences, 
Franklin Lakes, NJ) after washing with PBS (1 mL) to remove the loosely-attached cells 
from the scaffold surface. 1 mL of culture medium supplemented with 10% (v/v) Alamar 
Blue reactant (Biosource International, Camarillo, CA) was added to each well with the 
tissue disks. The serum content of the culture medium for the assay was kept constant for 
all samples as 10% v/v due to the interaction of Alamar Blue reagent with serum 
concentration.
315
 1 mL AB/DMEM mixture was placed into each of three empty wells as 
a negative control. Triplicate absorbance readings for each disc (n = 3) were averaged 
and the cellular metabolic activity (expressed as percentage Alamar Blue reduction) was 
calculated. Please refer to Section 5.2.6 for the details of the assay.  
6.2.7. Quantification of double stranded (ds)-DNA  
Briefly, HUV tissue disks (5 mm diameter) were extracted from the cultured scaffolds 
and washed with 1 mL PBS three times. Three constructs per dynamic (flow) culture 
duration and one construct per quasi-static (low flow) culture duration were tested for 
cellularity from the bioreactor study, with duplicate tissue disks tested from each region 
(Regions 1, 2 and 3). The disks were placed in cryovials, weighed wet and kept in liquid 
nitrogen over night. The samples were then lyophilized using an FD 2.5 freeze dryer 
(Heto-Holten, Gydevang, Denmark). Freeze-dried samples were stored at -20C or 
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immediately prepared for DNA extraction. Tissue disks were then digested in papain 
buffer (papain 125 µg/ml [EMD Biosciences, Inc., La Jolla, CA], 5 mM cysteine-HCl 
[Thermo Scientific, Rockford, IL], and 5 mM di-sodium EDTA [Fair Lawn, NJ] in sterile 
PBS) (10-200 mg tissue/mL) at 60°C overnight.
285, 388
 The papain sample solution was 
diluted to 0-25 mg/mL with TE buffer (10 mM Tris-HCl and 1 mM EDTA) (EMD, 
Gibbstown, NJ) in 50 mL NALGENE
®
 Oak Ridge centrifuge tubes (Thermo Fisher 
Scientific, Rochester, NY) and centrifuged at 21,000 g (Sorvall RC-5C centrifuge, 
Kendro Laboratory Products, Asheville, NC) for 5 min at room temperature.
389
 The 
supernatant was transferred to a new tube and samples were assayed for the 
quantification of hGFs (Please refer to Section 5.2.5). The standard dilutions were also 
prepared in papain digestion solution for accurate DNA quantitation. Three replicate 
fluorescence readings were taken from each sample and averaged. 
6.2.8. Gene Expression Profiling Using Quantitative Real-time Polymerase Chain 
Reaction (RT-PCR) 
To quantify the expression of specific genes in cultured hGFs, the RNA extracted from 
HUV scaffolds was first reverse transcribed to cDNA with reverse transcriptase and then 
the quantitative Real-time Polymerase Chain Reaction (qRT-PCR) was used to amplify 
the DNA.     
6.2.8.1. RNA Extraction  
Tissue samples were cut into 5 mm-diameter tissue disks using a stainless-steel puncher 
(each tissue disk weighs 20 mg). Then, each tissue disk was put into RNase-free 
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microfuge tubes and incubated in RNAlater (Ambion, Austin, TX) to preserve 
Ribonucleic acid (RNA) at 4C overnight. The tissue-to-RNAlater solution ratio was kept 
as 1:10 (v/v) to ensure that the solution thoroughly penetrates the tissue. The supernatant 
was then removed, and the samples were retrieved from RNAlater solution with sterile 
forceps, and the excess RNAlater solution was blotted away with an adsorbent paper 
towel. Then, the tissue disks were kept at -80C until the analysis. 
Prior to analysis, the eppendorf tubes having the tissue samples were placed in liquid 
nitrogen for at least 24 hr. Just before the analysis, the eppendorf tubes with the tissues 
were transferred to a Styrofoam container filled with liquid N2. On the other hand, the 
tissue pulverizer was first washed well with detergent, cleaned with ethanol, then RNAse 
decontamination solution and DNAse-free solutions. The pulverizer was then placed in a 
shallow container and pre-chilled with liquid nitrogen. The frozen tissues were then taken 
out of the eppendorf tubes and placed in the well of the pulverizer (Fig. 6.8). The 
pulverizer was then removed from the shallow container filled with liquid N2, placed on 
the lab bench and hammered on top to powder the tissue samples. The powdered-tissue 
was recovered quickly and put in eppendorf tubes and filled with 600 µl lysis/binding 





                   
Figure 6.8. Tissue pulverizer (crusher) used to digest the frozen tissue for RNA extraction.  
 
 
Total RNAs were extracted from the scaffolds using the RNAqueous

 -4PCR Kit 
(Ambion Inc., Austin, TX) according to the manufacturer’s protocol. This RNA 
extraction method on tissue samples is mainly based on lysing the cell membrane and 
rapidly inactivating the cellular ribonucleases.
390, 391
 
Briefly, 64% ethanol solution and wash solution #2/3 were prepared. At the same time, 
elution solutions (220 L) in RNase-free PCR 8-strip tubes (Eppendorf, Hamburg, 
Germany) were heated in a water bath set to 70-80C. An equal volume of 64% ethanol 
(600 L) was added to the lysate-tissue mixture and mixed gently but thoroughly by 
inverting the tube several times. Then, the lysate/ethanol mixture was drawn through a 










rpm for 1 min (National Labnet Co., Woodbridge, NJ). The solution is discarded and 700 
L of Wash Solution #1 was applied to the filter cartridges and centrifuged at 10,000 rpm 
for 1 min. Then, 1 mL of Wash Solution #2/3 added onto the cartridges and centrifuged 
for 1 min at 10,000 rpm. After that, a final centrifuge without putting any solution 
(10,000 rpm for 1 min) was performed to make sure all the wash solution is discarded 
from the cartridges. Then, elution solutions were taken out of the water bath and 
sequential aliquots of Elution Solution were pipetted to the center of the cartridges and 
centrifuged at 10,000 rpm. At the end, a total of 100 L RNA solution was collected in 
the collection tubes.  
In order to effectively remove trace DNA contamination, first 0.1 volume of 10X DNase 
1 Buffer (10 L) and then 1 L of DNase I was added to each tube containing RNA 
solution. The tubes were shaken well with finger tips, and incubated for 25 min at 37C. 
Then, 0.1 volume DNase Inactivation Reagent (10 L) was added to the sample to 
remove the DNase I from RNA and the divalent cations introduced by the DNase I 
Buffer. The tube was flicked gently to disperse the DNase Inactivation Reagent in the 
reaction and incubated for 2 min at room temperature. The sample was then centrifuged 
for 1 min at 10,000 rpm. The liquid phase containing the RNA was recovered, and used 
for cDNA synthesis and RT-PCR. The extracted RNA was stored at -80C until the 
analysis (the freeze-thaw cycle was applied only once for the RNA extracts). During the 
whole RNA extraction process, RNase-free pipette tips were used to handle the kit 
reagents and samples. 
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The concentration of the RNA solution was determined using a traditional 
spectrophotometer after a dilution in TE (10 mM Tris-HCl pH 8, 1 mM EDTA) (1:50 to 
1:100 dilution). The RNA concentration in g/ mL was calculated according to Eqn (8) 
while assuming an A260 of 1 was equivalent to 40 g RNA/ mL: 
 
           A260  dilution factor  40 = g RNA/mL                                                             (8) 
 
The RNA purity of the RNA solution was calculated by just taking the ratio of the 
absorbance values, A260 to A280 (the ratio should fall in the range of 1.8 to 2.1).  
6.2.8.2. Reverse Transcription (RT) 
The mRNA extracted from the tissue samples was reverse transcribed to complementary 
DNA (cDNA) using TaqMan Reverse Transcription Reagents (Applied Biosystems, 
Austin, TX). A 100-L RT reaction efficiently converts a maximum of 2 g total RNA to 
cDNA, so it is important that the starting RNA solution is diluted (if necessary) with 
RNase free water to adjust the final RNA concentration to a maximum of 2 g total RNA 
in 100 L RT reaction mixture (0.02 g/L). 
Briefly, for a total of 100 L RT reaction mixture, the nonenzymatic components (10 L 
of 10X RT Buffer, 22 L MgCl2 (25 mM), 20 L deoxyNTPs Mixture (2.5 mM), 2.5 L 
Oligo d(T)16 (50 M) and 2.5 L Random Hexamers (50 M) were combined in an 
RNA-free microcentrifuge tube and vortexed briefly. Then, the enzymatic components- 2 
L RNase Inhibitor (20 U/L), 2.5 L MultiScribe Reverse Transcriptase (50 U/L) and 
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the RNA solution (38.5 L) were added and the RT reaction mixture was mixed by 
inverting the tube gently a couple of times. By using a thermal cycler (Mastercycler ep 
realplex, Eppendorf, Westbury, NY), reaction mixture was incubated at 25°C for 10 min, 
then RT reaction was performed at 48°C for 30 min, after which the reaction was stopped 
by heating of the mixture at 95°C for 5 min. The instrument was warmed up for at least 
15 min before starting the reverse transcription. The cDNA concentration was determined 
by measuring the absorbance at 260 nm in a spectrophotometer.
392
 The cDNA was stored 
at -20°C until required.  
6.2.8.3. Quantitative Real-time Polymerase Chain Reaction (qRT-PCR) 
The cDNA aliquots were then subjected to quantitative reverse transcription-polymerase 
chain reaction (qRT-PCR) to investigate the ability of the cultured hGFs to synthesize the 
extracellular matrix (ECM) components. A Power SYBR Green PCR Master Mix kit 
(Applied Biosystems, Foster City, CA) was used for the RT-PCR reaction. SYBR Green I 
is an asymmetric cyanine dye that has a strong affinity to dsDNA.
393
 The assay is based 
on measuring the increase in the fluorescent dye’s signal that is proportional to the 
amount of DNA produced in each cycle.
394
  
Amplification of cDNA was performed in a 25 L RT-PCR reaction containing 3 L 
forward primer (3 M),  3 L reverse primer (3 M),  7 L cDNA as template and 12 L 
SYBR Green Master Mix. The reaction mixture was added to the RT-PCR 96- well plate 
(Eppendorf AG, Hamburg, Germany) and sealed with cap strips (Eppendorf AG, 
Hamburg, Germany).   
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The forward and reverse primer sequences for collagen (COL) (COL-I and COL-III), 
matrix metalloproteinases (MMP) (MMP-1 and MMP-2), MMP tissue inhibitor (TIMP) 
(TIMP-1) and decorin were listed in Table 6.3. Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH; a housekeeping gene) was used to normalize marker gene 
expression in each sample.  
 
TABLE 6.3. PRIMER SEQUENCES USED IN THE STUDY 
Gene                                 Primer    Amplicon Size 
           (bp) 
Col-I 
395
 Forward : GTGGGCTTCCTGGTGA 




  Forward : GGTACTCCTGGTCTGCA 






Forward : GGT GAT GAA GCA GCC CAG               






Forward : CCT CTC CAC TGC CTT CGA TAC ACC 






Forward: AGT CAA CCA GAC CAC CTT ATA CCA 




  Forward: GATCACCAAAGTGCGAA      




 Forward: ATGCAACGGATTTGGTCGTAT 




RT-PCR amplification was performed in a thermal cycler and the amplification 




TABLE 6.4. RT-PCR AMPLIFICATION CONDITIONS FOR THE PRIMERS 











Col-I  40   94C for 1 min   55C for 2 min   72C for 3 min 









40   94C for 1 min   60C for 2 min   72C for 3 min 
TIMP-1 
 
40   94C for 1 min   60C for 2 min   72C for 3 min 
Decorin 40   94C for 1 min   50C for 30 sec   72C for 1 min 
GAPDH
 
40   95C for 15 sec   56C for 15 sec   72C for 30 sec 
*
+ 72 C 10 min to finalize extension. 
 
At the end of the RT-PCR reaction, melting curves were analyzed. Melting curves were 
obtained by heating at a 10 min ramp time from 60 to 95C. The quantification of the 
RT-PCR results was achieved using the comparative threshold method. Basically, the 
threshold cycle (CT) of each gene of interest was normalized to the housekeeping gene 
yielding the relative expressions.
399, 400
 The number of required cycles for RT-PCR 
response curves to reach a specific threshold fluorescence signal level is called the CT.
401
 
Fig. 6.9 illustrates the CT values obtained from the RT-PCR response curves.  
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Figure 6.9. Schematic illustration of RT-PCR response curve, where a threshold level sufficiently 













                       Ratio   =  
 
Etarget and Eref. represent the RT-PCR efficiencies for the target and reference (GAPDH) 
genes, respectively. The RT-PCR efficiencies (E) were calculated using the Relative 
Expression Software Tool-XL (REST-XL).
403, 404
 The CT values were determined by the 
Etarget  
CT, target  
(9) 
Eref.  
CT, ref.  
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instrument software, and CT, target and CT, ref. were calculated by subtracting the CT 
value of the sample from the CT value of the control [CT = CT (control) - CT 
(sample)] for the target and reference genes, respectively. Thus, the fold increase 
(upregulation) or decrease (downregulation) of the target gene in the sample was 
calculated relative to the control sample. The seeded and statically cultured HUV tissue at 
t = 0 was used as control. 
6.2.9. Histological Analysis Using Light Microscopy 
Histological analysis was conducted to visualize the cellular attachment and migration 
into the acellular tissue. Briefly, tissue samples from different zones (n = 6) were fixed 
and dehydrated with graded ethanol solutions before embedding in paraffin, as described 
in Section 5.2.8. Paraffin-embedded blocks were serially sectioned at 7 m thickness. 
Tissue mounting, deparaffinization and rehydration steps were also performed as 
described in Section 5.2.8. Hematoxylin and eosin (H&E) staining was used to 
investigate the tissue architecture. The slides were first deparaffinized in Clearite (3, 3 
min each), and dehydrated in 100 EtOH (2, 3 min each) and 95% EtOH (2, 1 min 
each). After dehydration in tap water, the slides were stained with hematoxylin for 5 min 
and rinsed with tap water. Then the slides were kept in 0.2% Ammonia-water solution for 
1 min and placed in running water for 5 min. The sections were stained with eosin for 1 
min followed by changes of 95% EtOH (2, 1 min each), 100% EtOH (3, 3 min each) 
and clearite (3, 3 min each).
405
 Finally, the slides were mounted and histologic images 
were obtained utilizing the Nikon 80i microscope and DXM1200C camera for brightfield 
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microscopy. The histology images were captured with NIS-Elements software (Nikon 
Instruments, Melville, NY). 
6.2.10. Immunohistochemistry  
The immunohistochemistry technique was used to identify the location and distribution 
of a target antigen in the hGFs by staining with a specific antibody.
406
 Antibodies are 
immunoglobulins that bind to different natural and synthetic antigen proteins that 
stimulate the production of and react specifically with antibodies.
407
   
The immunohistochemical analysis was conducted for the formalin-fixed paraffin-
embedded sections according to the protocol developed by May et al.
408
 The formalin 
fixation forms inter- and intramolecular cross-linkages in antigen proteins that may 
preclude their recognition by a specific antibody.
409
 Therefore, heat-induced epitope 
retrieval technique was applied to cleave these cross-links by utilizing a pressurized 
decloaking chamber (Biocare Medical, Concord, CA) in citrate buffer (pH 6.0) at 99C 
for 18 min.
410
 Then, slides were incubated in 3% hydrogen peroxide at room temperature 
for 20 min to quench any endogenous peroxidase activity and thus block non-specific 
staining.
411, 412
 The slides were incubated with primary antibody [anti-vimentin 1:300 
(rabbit), (Santa Cruz Biotechnology, Santa Cruz, CA)] at 4C overnight.
413
 Anti-vimentin 
antibody has been reported to recognize a large number of cell types, including 
fibroblasts, macrophages, mesenchymal cells, and so forth.
414, 415
 Anti-vimentin antibody 
has also been used as a marker to detect the vimentin filaments within the human gingival 
fibroblast (hGF) cytoskeleton.
416, 417
 After incubation with primary antibody, the slides 
were labeled with rabbit polymer-horseradish peroxidase (HRP) secondary (Biocare 
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Medical) for 25 min at room temperature. The secondary antibody links to the bound 
primary antibody for detection purposes.
418
 Then, the visualization of the bound immune 
complex was obtained developing the slides with the chromogen diaminobenzidine 
(DAB) (Sigma, St. Louis, MO) that initiates a colorimetric reaction and causes the 
immunopositive cells appear brown.
419
 The immunohistochemistry images were obtained 
utilizing the Nikon 80i microscope and DXM1200C camera for brightfield microscopy. 
Images were captured with NIS-Elements software (Nikon Instruments, Melville, NY). 
Immunohistochemical staining was conducted for all the samples and the control at the 
same time.  
6.2.11. Sample Analysis and Statistical Data Interpretation 
Regarding the assays, tissue constructs to be tested were divided into four groups: (1) 
Static Control (SC) - Static cultures of acellular HUV membranes in petri dishes; (2) 
Static Sample (SS) - Static cultures of HUV scaffolds reseeded with hGFs in petri dishes; 
(3) Low Flow Sample (LFS) – Quasi-static cultures of reseeded HUVs within the 
bioreactor assembly; (4) Flow Sample (FS) - Continuous flow cultures of reseeded HUVs 
within the bioreactor assemblies. The description and the coding of the samples were 







TABLE 6.5. SAMPLE DESCRIPTION AND CODING USED IN DATA ANALYSIS  
Sample Description  Sample Coding 
Flow Sample from Bioreactor Region 1 (Entrance) FS1 
Flow Sample from Bioreactor Region 2 (Central) FS2 
Flow Sample from Bioreactor Region 3 (Exit) FS3 
Low Flow Sample from Bioreactor Region 1 (Entrance) LFS1 
Low Flow Sample from Bioreactor Region 2 (Central) LFS2 
Low Flow Sample from Bioreactor Region 3 (Exit) LFS3 
Static Sample  SS 
Static Control  SC 
 
 
The 7- and 28-day flow experiments were repeated three times with three flow and one 
low flow control per group, resulting n = 9 experimental flow and n = 3 low flow control 
samples. The sample size was three (n = 3) for the static seeded and static acellular 
samples for each culture period (t = 0, 7 and 28 days).   
The statistical software PASW 18 for Windows (SPSS, Chicago, IL) was used to perform 
the statistical analysis for cellular metabolic activity and proliferation assays. 
Independent samples t-test was used to test for significant differences between 2 test 
groups. One-way analysis of variance (ANOVA) was used to test for significant 
differences among multiple test groups. One-way ANOVA was followed by Tukey or 
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Games-Howell post hoc tests depending on if the equal variance assumption was valid. 
To assess for differences in gene expression profiles, REST-XL was used.
402, 420
 
Statistical significance was set at p < 0.05 for all tests. All values are expressed as mean ± 
standard deviation.  
6.3. RESULTS 
6.3.1. Cellular Proliferation and Metabolic Activity within the HUV Bioscaffolds 
Proliferation of hGFs, related to the DNA content within the HUV scaffolds, was 
assessed using the Picogreen assay and the change in DNA content over time was 
presented in Fig. 6.10. The concentration of DNA in HUV tissue (micrograms per mg 





















Figure 6.10. DNA content within the HUV tissue was quantified using the Picogreen assay and 
expressed in g DNA per mg tissue. DNA content was found to vary with sample type and 






Significant differences in tissue DNA content were observed amongst different test 
samples (One-way ANOVA, Games-Howell post hoc, p < 0.05) and listed in Tables 6.6 
and 6.7 for 7 day- and 27 day-cultures, respectively.  The DNA concentration (g DNA 
per mg wet tissue) increased significantly from day 7 to day 28 (Independent samples t-
test, p < 0.05) for the samples coded – SS, FS1, FS2, and FS3 (See Table 6.5). 
 
TABLE 6.6. DIFFERENCES IN TISSUE DNA CONCENTRATION AMONG SAMPLES AT DAY 7. 




SS FS1 FS2 FS3 LFS1 LFS2 LFS3 
SS  √ √  √ √  
FS1 √  √ √ √ √  
FS2 √ √  √ √ √ √ 
FS3  √ √  √ √  
LFS1 √ √ √ √  √  
LFS2 √ √ √ √ √   









TABLE 6.7. DIFFERENCES IN TISSUE DNA CONCENTRATION AMONG SAMPLES AT DAY 28. 




SS FS1 FS2 FS3 LFS1 LFS2 LFS3 
SS   √  √ √ √ 
FS1   √  √ √ √ 
FS2 √ √  √ √ √ √ 
FS3   √  √ √ √ 
LFS1 √ √ √ √    
LFS2 √ √ √ √    
LFS3 √ √ √ √    
 
 
The number of human gingival fibroblasts (hGFs) within HUV tissue disks was 
computed using Eqn. 7 and found to vary with culture time and sample type (Fig. 6.11). 
Significant differences were observed amongst the test samples (One-way ANOVA, 
Games-Howell post hoc, p < 0.05) and listed in Tables 6.8 and 6.9 for 7 day- and 27 day-
cultures, respectively. The hGF content of HUV disks increased significantly from day 7 




















Figure 6.11. Proliferation of hGFs cultured within the HUV scaffolds was found to vary with 








TABLE 6.8. VARIATION IN HGF POPULATION FOR DIFFERENT SAMPLE TYPES AT DAY 7. SYMBOL 
√ REPRESENTS THE STATISTICALLY SIGNIFICANT DIFFERENCES SET AT 0.05 LEVEL 
Sample 
Type  
SS FS1 FS2 FS3 LFS1 LFS2 LFS3 
SS  √ √ √ √ √ √ 
FS1 √  √ √ √ √ √ 
FS2 √ √  √ √ √ √ 
FS3 √ √ √  √ √ √ 
LFS1 √ √ √ √  √  
LFS2 √ √ √ √ √   
LFS3 √ √ √ √    
 
TABLE 6.9. VARIATION IN HGF POPULATION FOR DIFFERENT SAMPLE TYPES AT DAY 28. 
SYMBOL √ REPRESENTS THE STATISTICALLY SIGNIFICANT DIFFERENCES SET AT 0.05 LEVEL 
Sample 
Type  
SS FS1 FS2 FS3 LFS1 LFS2 LFS3 
SS   √  √ √ √ 
FS1   √  √ √ √ 
FS2 √ √  √ √ √ √ 
FS3   √  √ √ √ 
LFS1 √ √ √ √    
LFS2 √ √ √ √    






The metabolic activity of hGFs seeded on HUV scaffold was assessed and the differences 
between the experimental groups and control group were evaluated (See Table 6.5 for the 
detailed description of the sample types). The percent (%) Alamar blue (AB) reduction 
per tissue disk data showed that static samples (SS) demonstrated higher metabolic 
activity than the static controls (SC) (Independent samples t-test, p < 0.05) at day 0 (Fig 
6.12). Statistically significant differences in metabolic activity were observed amongst 
different sample types at day 7 and day 28 (p < 0.05; Tukey’s post-hoc test with one-way 







      
Figure 6.12. Percent (%) Alamar blue (AB) reduction per tissue disk versus sample type. 
Viability of the cultured hGFs in the HUV scaffolds (n = 3-9) was assessed with AB and was 
found to vary with culture time. Values are expressed as meanSD. 
*
 denotes statistically 






The percentage (%) AB reduction per tissue disk for the static sample (SS) at day 7 was 
significantly greater than at day 0, and at day 28 was significantly greater than day 7 
(One-way ANOVA, Tukey’s post hoc test, p < 0.05). The % AB reduction per tissue disk 
increased significantly from day 7 to day 28 (Independent samples t-test, p < 0.05) for the 
samples coded – FS1, FS2, and LFS3 (see Table 6.5), indicating the continuity of cellular 
metabolic activity over culture period. However, there was no statistically significant 
change in cellular metabolic activity for the samples coded FS3, LFS1, and LFS3 
between days 7 and 28.     
The statistical differences in %AB reduction among different sample types at days 7 and 
28 were also tabulated in Tables 6.10 and 6.11, respectively.  
 
TABLE 6.10. DIFFERENCES IN PERCENT (%) ALAMAR BLUE (AB) REDUCTION PER TISSUE DISK 
AMONG SAMPLES AT DAY 7. SYMBOL √ REPRESENTS THE STATISTICALLY SIGNIFICANT 
DIFFERENCES SET AT 0.05 LEVEL  
Sample 
Type  
SS SC FS1 FS2 FS3 LFS1 LFS2 LFS3 
SS  √ √  √ √   
SC √   √   √  
FS1 √   √   √  
FS2  √ √  √ √  √ 
FS3 √   √     
LFS1 √   √     
LFS2  √ √      




TABLE 6.11. DIFFERENCES IN PERCENT (%) ALAMAR BLUE (AB) REDUCTION PER TISSUE DISK 
AMONG SAMPLES AT DAY 28. SYMBOL √ REPRESENTS THE STATISTICALLY SIGNIFICANT 
DIFFERENCES SET AT 0.05 LEVEL 
Sample 
Type  
SS SC FS1 FS2 FS3 LFS1 LFS2 LFS3 
SS  √ √ √ √ √  √ 
SC √  √ √ √ √ √  
FS1 √ √  √ √   √ 
FS2 √ √ √  √ √ √ √ 
FS3 √ √ √ √   √  
LFS1 √ √  √   √  
LFS2  √  √ √ √  √ 
LFS3 √  √ √   √  
 
 
By combining the hGF number assessed by the Picogreen Assay (cells per tissue disk) 
(Fig. 6.11), and the % Alamar blue (AB) reduction per tissue disk data (Fig. 6.12), we 
obtained the cellular metabolic activity (%AB reduction per cell) as shown in Figure 
6.13. The % AB reduction per cell decreased significantly from day 7 to day 28 










Figure 6.13. The Alamar blue (AB) reduction per cell within HUV disks after 7 days and 28 days 





The statistically significant differences among different tissue types (One-way ANOVA, 
Tukey’s test, p < 0.05) were indicated in Tables 6.12 and 6.13, respectively.  
TABLE 6.12. DIFFERENCES IN PERCENT (%) ALAMAR BLUE (AB) REDUCTION PER CELL VALUES 
AMONG SAMPLES AT DAY 7. SYMBOL √ REPRESENTS THE STATISTICALLY SIGNIFICANT 
DIFFERENCES SET AT 0.05 LEVEL 
 
Sample Type  SS FS1 FS2 FS3 LFS1 LFS2 LFS3 
SS     √ √ √ 
FS1     √ √ √ 
FS2    √ √ √ √ 
FS3   √  √ √ √ 
LFS1 √ √ √ √  √ √ 
LFS2 √ √ √ √ √   
LFS3 √ √ √ √ √   
 
TABLE 6.13. DIFFERENCES IN PERCENT (%) ALAMAR BLUE (AB) REDUCTION PER CELL VALUES 
AMONG SAMPLES AT DAY 28. SYMBOL √ REPRESENTS THE STATISTICALLY SIGNIFICANT 
DIFFERENCES SET AT 0.05 LEVEL 
 
Sample Type  SS FS1 FS2 FS3 LFS1 LFS2 LFS3 
SS   √ √ √ √ √ 
FS1   √ √ √ √ √ 
FS2 √ √   √ √ √ 
FS3 √ √   √ √ √ 
LFS1 √ √ √ √  √ √ 
LFS2 √ √ √ √ √  √ 
LFS3 √ √ √ √ √ √  
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6.3.2. Assessment of Gene Expression Profiles for the Cultured hGFs 
The purity of total RNA extracted from the cultured HUV scaffolds was checked by a 
spectrophotometer and the wavelength absorption ratio (260/280 nm) was between 1.8 
and 2.0 in all preparations.  
The mRNA levels of COL-I, COL-III, MMP-1, MMP-2, TIMP-1 and decorin (Table 6.3) 
were analyzed in the hGFs cultured samples for 7 and 28 days by reverse-transcription 
polymerase chain reaction (RT-PCR). The relative expression levels (upregulation or 
downregulation) for the genes COL-I, COL-III, MMP-1, MMP-2, TIMP-1 and decorin 
compared to the control samples, were graphically illustrated in Figs. 6.14-6.20. 
Expression of these genes, however, remained below the detection level for the samples 












Figure 6.14. mRNA levels of COL-I in hGFs in culture at day 7 and day 28. Seeded HUV 
samples under static culture (t = 0) served as controls. Fold changes were obtained by 










Figure 6.15. mRNA levels of COL-III in hGFs in culture at day 7 and day 28. Seeded HUV 
samples under static culture (t = 0) served as controls. Fold changes were obtained by 
















Figure 6.16. mRNA levels of MMP-1 in hGFs in culture at day 7 and day 28. Seeded HUV 
samples under static culture (t = 0) served as controls. Fold changes were obtained by 











Figure 6.17. mRNA levels of MMP-2 in hGFs in culture at day 7 and day 28. Seeded HUV 
samples under static culture (t = 0) served as controls. Fold changes were obtained by 












Figure 6.18. mRNA levels of TIMP-1 in hGFs in culture at day 7 and day 28. Seeded HUV 
samples under static culture (t = 0) served as controls. Fold changes were obtained by 









Figure 6.19. mRNA levels of decorin in hGFs in culture at day 7 and day 28. Seeded HUV 
samples under static culture (t = 0) served as controls. Fold changes were obtained by 












6.3.3. Histological Assessment of HUV Scaffolds   
Hematoxylin & Eosin (H&E) staining technique was used to visualize the cellular 
components within the human umbilical vein (HUV) scaffolds. The histological analysis 
demonstrated the native cells of the HUV before decellularization (Figs. 6.20A and 
6.20B), and confirmed a complete removal of smooth muscle cells and endothelial cells 




Figure 6.20. H&E-stained HUV scaffolds before decellularization ((A)- 4X magnification, (B)- 
20X magnification), and after decellularization ((C)- 4X magnification, (D)- 20X magnification) 
with SDS surfactant for 24 h. The blue arrow indicates the lumenal surface; the brown arrow 
indicates the ablumenal surface. The scale bars for the 4X magnification indicate 500 m, and 






The histological analysis at t = 0 revealed that the control samples (Fig. 6.21A) were 
devoid of hGFs, whereas the cells adhered on the scaffold surface and migrated further 
through the tissue for the static samples (SS) (Fig. 6.21B).    
 
   
Figure 6.21. Histological analysis for the sample control (SC) (A) and static sample (SS) (B) at t 
= 0. The sample control was observed to be devoid of cellular components, whereas the cells 
were visualized (indicated by arrows) within static samples. The black arrows indicate hGFs on 
the surface and interior parts of the re-cellularized human umbilical vein. The blue arrow 
indicates the lumenal surface; the brown arrow indicates the ablumenal surface. Cells were round 
and spindle-shaped throughout the scaffolds. Original magnification: 20X. Scale bars indicate 




Hematoxylin and Eosin (H&E) staining of the control and test samples at day 7 and day 
28 are presented in Figs. 6.22 and 6.23, respectively. The staining demonstrated variation 








           
           
           
          
Figure 6.22. Histology for the sample control (SC) (A), static sample (SS) (B), flow sample 1 
(FS1) (C), flow sample 2 (FS2) (D), flow sample 3 (FS3) (E), low flow sample 1 (LFS1) (F), low 
flow sample 2 (LFS2) (G), and low flow sample 3 (LFS3) (H) at day 7. Original magnification: 
20X. Purple stain shows the cellular components, and the brown arrow indicates the ablumenal 









        
        
        
        
Figure 6.23. H&E staining for sample control (SC) (A), static sample (SS) (B), flow sample 1 
(FS1) (C), flow sample 2 (FS2) (D), flow sample 3 (FS3) (E), low flow sample 1 (LFS1) (F), low 
flow sample 2 (LFS2) (G), and low flow sample 3 (LFS3) (H) at day 28. Purple stain shows the 
cellular components, and the brown arrow indicates the ablumenal surface. Scale bars indicate 







6.3.4. Immunohistochemical Analysis of HUV Scaffolds   
Immunostaining technique adopted in this study required the binding of the primary antibody 
vimentin to cultured hGFs, and then the detection and visualization of bound vimentin with rabbit 
polymer-horseradish peroxidase (HRP). The immunohistochemical micrographs show that the 
antibody to vimentin stained the hGFs (brown stains). The negative staining for vimentin in the 
decellularized tissue revealed the complete removal of the cellular components from the scaffold 
(Figs. 6.24A and 6.24B). The attachment and migration of the hGFs within the HUV scaffold at t 
= 0 was demonstrated in Figs. 6.24C and 6.24D.  
 
       
       
 
Figure 6.24. The immunohistochemical staining of the HUV scaffolds at t = 0. The static control 
(SC) samples ((A)- 20X magnification, (B)- 40X magnification) demonstrate no fibroblastic 
component, whereas fibroblasts are clearly visualized (brown stains) for the static samples (SS)  
((C)- 20X magnification, (D)- 40X magnification). The brown arrow indicates the ablumenal 
surface. Scale bars for the 20X magnification images indicate 100 m, and scale bars for the 40X 






Immunostaining of the cultured HUV samples for 7 and 28 days are presented in Figs. 
6.25 and 6.26, respectively. The acellular HUV sections showed negative staining for 
vimentin (Figs. 6.25A and 6.26A), whereas the cells showed strong positive staining for 
all the other test samples (Figs. 6.25B-H and 6.26B-H). Variation in hGF migration and 






















             
             
             
             
Figure 6.25. Immunohistochemistry of the HUV scaffolds at day 7 - sample control (SC) (A), 
static sample (SS) (B), flow sample 1 (FS1) (C), flow sample 2 (FS2) (D), flow sample 3 (FS3) 
(E), low flow sample 1 (LFS1) (F), low flow sample 2 (LFS2) (G), and low flow sample 3 
(LFS3) (H) at day 7. The blue and brown arrows indicate the lumenal and ablumenal surfaces, 







           
           
           
           
Figure 6.26. Immunohistochemical photomicrographs of the HUV scaffolds at day 28 - sample 
control (SC) (A), static sample (SS) (B), flow sample 1 (FS1) (C), flow sample 2 (FS2) (D), flow 
sample 3 (FS3) (E), low flow sample 1 (LFS1) (F), low flow sample 2 (LFS2) (G), and low flow 
sample 3 (LFS3) (H) at day 28. The blue arrow indicates the lumenal surface; brown arrow 









6.4. DISCUSSION  
Guided tissue regeneration (GTR) technique has been an effective strategy to treat 
diseased periodontal tissues while employing space-maintaining barriers that coordinate 
the healing processes. Numerous GTR membranes have been proposed for use in 
periodontal wound healing and regeneration.
421-423
 In this study, we assessed the ability of 
the human umbilical vein (HUV) to function as a periodontal GTR membrane.  
The human umbilical vein (HUV) has been well documented for its use as a vascular 
conduit in numerous studies,
424-426
 as a mesenchymal stromal cell (MSC) reservoir for 
several tissue engineering applications,
427-430
 and as a scaffolding material in tissue 
replacement for various defects.
431, 432
 We have previously introduced the HUV as a 
surgical barrier for periodontal GTR applications. With this scaffold, the ablumenal 
surface enabled cells to penetrate into the extracellular matrix (ECM), whereas the 
lumenal surface acted as a barrier and inhibited cell migration.
29
 Upon decellularization, 
the HUV graft possessed larger void spaces compared to the native tissue that may be 
advantageous by increasing the mass transfer of nutrients and gases.
433
 While these in 
vitro assessments show significant promise, further development of these systems using 
bioreactors to precisely control perfusion conditions may improve the biological 
interactions and tissue functionality. 
The aim of this study was to design a modified parallel-plate bioreactor system that 
broadly mimics conditions during periodontal wound healing and then to understand the 
role these conditions have on the biological function of the hGFs. The HUV membrane 
was inserted between the two flow compartments of the bioreactor with the HUV’s 
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lumenal side facing the top compartment perfused at low shear rates to actively 
reorganize and remodel the ECM.
434, 435
 The ablumenal side of the scaffold was placed in 
contact with the lower flow compartment resembling the wound space (Fig. 6.1). The 
upper flow compartment was circulated with culture media having no glucose in order to 
create a chemotactic gradient that may drive hGF migration from the ablumenal side 
through the scaffold toward the lumenal surface. In addition, flow was perfused through 
both compartments of the bioreactor simulating the physiological pulsating frequency.
436, 
437
 We hypothesized that several factors including the pulsation rates through the 
scaffold, the central region (region 2) of the scaffold being in direct contact with the flow 
and the change in the gas, nutrient and waste concentration of the media through the 
bioreactor (from region 1 to region 3) might lead to zonal variations in the biological 
response of the cultured hGFs. Our second hypothesis was that the continuous flow 
conditions would improve the functional activity of the cells relative to static and quasi-
static conditions.  
The DNA-quantification tests revealed that the DNA concentration was higher for the 
continuous flow samples (FS) compared to the low flow (quasi-static) samples (LFS) for 
days 7 and 28. This might be due to the provision of the necessary mass transport 
conditions that trigger cellular growth and proliferation for the continuous flow cultures. 
Another possible explanation would be up-regulation of epidermal growth factor (EGF) 
due to perfusion induced stimulation that directs the enrichment of DNA content.
94
   
Assessment of cellular metabolic activity showed significant differences in cell activity 
between regions 1 and 3 for both low flow samples (LFS) and flow samples (FS) at day 
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28, also showing a progressive decrease in activity over time. McGuigan et al.
438
 
observed a similar trend of a decrease in cellular metabolic activity over time with the 
human umbilical vein endothelial cells (HUVECs) seeded on polyethylene-based 
constructs. The slower growth associated with the lower cellular metabolic activity under 
continuous flow conditions correlates well with the cell density data. Reduced or slowing 
metabolic activity of the hGFs cultured on decellularized scaffolds and their controls has 
several possible explanations, including contact inhibition, a shift in environmental niche 




To elucidate the biological activity of the cultured hGFs in vitro, we furthered our studies 
by monitoring their expression levels for collagen types I and III (COL-I and COL-III), 
matrix metalloproteinase-1 and -2 (MMP-1, MMP-2), tissue inhibitor of MMP-1 (TIMP-
1) and decorin. COL-I and COL-III are the most abundant ECM components of the 
gingival connective tissue.
37
 The strongest up-regulation observed in HUV scaffolds 
(16.7-fold) was for COL-I that is essential for maintenance of tensile resistance and 
regulation of cell adhesion on the scaffold surface.
440, 441
 Tissue COL- I content increases 
in the initial stages of wound healing due to the conversion of type III collagen to type 
I.
442
 COL-III is not only involved in reinforcement and support of tissues, but also in 
vascular proliferation during the early wound healing period.
443
 We found that flow-
stimulated cultures did not demonstrate higher collagen producing activity compared to 
their static controls.  
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Decorin is a small leucine-rich proteoglycan (SLRP) that plays an important role in 
several biological events, including cell adhesion, proliferation and differentiation.
444, 445
 
In addition, decorin is also known to be an important mediator leading to the fibrillation 
process, affecting the size of the collagen fibrils and construct linkages between the 
collagen molecules.
446, 447
 Interestingly, no significant upregulation of decorin was 
observed on any samples at day 7 or 28. We believe that this result could be related to the 
matrix transforming growth factor beta (TGFβ1) inhibiting decorin expression by the 
gingival fibroblasts.
448
 TGFβ1 binds with high affinity to decorin to form inactive 
complexes.
449
 Although the mechanism of action of TGFβ1 on the expression of decorin 
is dependent on the cell type,
450
 over expression of TGFβ1 by the gingival fibroblasts 
may disturb the neutralization reaction with decorin, and thus suppress its expression.        
Tissue remodeling events require the dynamic changes of cell-matrix interactions while 
regulating tissue homeostasis. An orchestrated cascade of event leads to the synthesis and 
degradation of extracellular proteins during remodeling. In this continuum, oral 
fibroblasts express the tissue degrading MMPs, such as MMP-1 and MMP-2 that cleave 
the bonds between collagen fibrils.
451, 452
 As a regulatory action, tissue inhibitors of 
MMPs (TIMPs) function to suppress the activity of MMPs.
453
 TIMP-1 has been proposed 
to be the major inhibitor of gingival tissue MMPs.
454
 In addition, TIMP-1 has been 
suggested to be a mediator of cellular growth, differentiation and migration,
455
 and renal 
fibrosis through inflammatory pathways.
456
 It is inferred from our results that the 
continuous flow conditions activate the MMP-2 expression by the gingival fibroblasts, 
however, for the expression of MMP-1, no significant stimulatory effect by the flow 
conditions was noted. The studies also demonstrated a significant difference between 
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flow perfusion culture (5.4-fold upregulation) and static culture (no noticeable up or 
downregulation) in their mRNA expression levels for TIMP-1 only at day 7.  
The real-time PCR results revealed regional and time-dependent changes in gene 
expression patterns. However, not all the regions remained above the detection level 
indicating relatively small RNA concentrations. To overcome this problem, small 




Histology and immunohistochemistry analyses confirm that the decellularization process 
effectively removed the cellular and nuclear components and the remaining HUV 
scaffold allowed the hGFs to attach on the scaffold surface, migrate and further 
proliferate. Immunolocalization of the hGFs was achieved by labeling the cells with anti-
vimentin antibody. Vimentin is an intermediate filament protein of adult mammalian 
mesenchymal cells that plays an important role in cellular mechanics and cytoskeletal 
organization.
459, 460
 Although not specific to human gingival fibroblasts (hGFs), positive 
staining for anti-vimentin in the hGF-seeded scaffolds demonstrated immunoreactivity of 
the protein in the cell cytoskeleton within the scaffold.
461
 Cells within the 28-day 
bioreactor cultures were shown to migrate toward the HUV’s lumenal surface in response 
to the nutrient gradient. Furthermore, immunolocalization in hGFs showed that cellular 
migration was greatly improved for the continuous flow samples (FS) compared to the 
low flow samples (LFS) over a 28 day culture period.   
In this work, we have studied the influence of the regional variations in the bioreactor on 
the biological functioning of the hGFs that could be pronounced more for longer culture 
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durations. In addition, the current bioreactor design can be improved towards a 
biomimetic environment in several ways to reflect more realistic tissue integration for 
clinical applications, such as coating the bioreactor surfaces resembling the tooth surface 
(region 1) and the alveolar bone surface (region 3) with coating agents having similar 
composition, and circulating a blood-like fluid on the side of the bioreactor mimicking 
the wound site.  
6.5. CONCLUSIONS 
Dynamic tissue culture systems have been investigated and tested for their ability to 
modulate tissue repair and regeneration processes. These in vitro investigations are an 
indirect assessment of in vivo studies, however they are strong indicators of what we 
might expect with host cell/tissue. Evidence shows that mechanical stimulation coupled 
with the chemical composition gradients created through the scaffold enhances cell 
metabolic functioning, proliferation, differentiation and synthesis of the important ECM 
components. For future studies, in vivo assessments should be conducted to confirm the 











Tissue engineering requires the development of scaffolds and materials with a 
combination of biological and mechanical properties that facilitate appropriate cell-
matrix interactions, and ultimately regenerate normal tissue structure and function. A 
further challenge, depending on the clinical situation, is that these complex biological 
events often must occur along with ongoing functional forces and movement. In these 
situations, appropriate matching of biomechanical properties between implanted 
materials and native tissues may be crucial. 
While the studies described here may have broader clinical and biological implications, 
they were conducted within the context of periodontal guided tissue regeneration (GTR).  
In this widely employed technique, a physical barrier or scaffold is positioned between 
the gingival tissue and underlying bone defect.  This is designed to provide a protected 
healing environment in which undifferentiated cells from the remaining periodontal 
ligament can repopulate and regenerate the defect, while the overlying barrier is 
gradually resorbed and incorporated into the adjacent tissues.  While the feasibility and 
efficacy of this technique is supported by a number of clinical studies, results are not 
always predictable and post-operative complications, particularly barrier exposure, are 
common.  It is obvious that the ideal materials and techniques have yet to be developed.  
A particular gap in knowledge is the relative lack of information regarding the 
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biomechanical properties of various oral tissues and how these compare to those of 
materials employed in periodontal GTR. 
These studies began with a detailed analysis of the biomechanical properties of porcine 
oral soft tissues. It was found that the biomechanical properties of oral tissues were 
highly region-specific and correlated well with tissue architecture. Next, experiments 
were conducted on the human umbilical vein (HUV), as a potential scaffold material for 
use in periodontal GTR. Biomechanical analysis showed that the HUV mechanical 
properties were influenced greatly by its composite structure. Further, it was noted that 
the HUVs biomechanical characteristics were comparable to those of porcine tissues. 
Culturing human gingival fibroblasts on the HUV showed that the material demonstrated 
as a biologic barrier to promote cell migration and proliferation during the initial phases 
of tissue remodeling. In the final set of experiments, a novel bioreactor system was 
developed. This system provided individually adjustable flow chambers above and below 
the scaffold material in order to model the tissue compartments of a periodontal wound or 
defect. Using this system, concomitant improvement in the biological response of cells 
and tissue was achieved. Taken together, these studies exhibit promising results about the 
potential role of HUV in periodontal GTR and point toward several avenues for future 







SUMMARY AND FUTURE DIRECTIONS  
 
In this study, the potential and further development of human umbilical vein (HUV)-
derived scaffold as a guided tissue regeneration (GTR) membrane have been investigated. 
Besides its use as a GTR membrane, the HUV-derived scaffold could also be investigated 
for its application as an oral mucosal substitute. For that purpose, the co-culture of the 
HUV membrane with both human gingival fibroblasts (hGFs) on the ablumenal surface 
and the oral keratinocytes on the lumenal side is essential. Therefore, as further steps of 
the project, the potential of the decellularized HUV to support keratinization when seeded 
with oral keratinocytes on its lumenal side should be examined.  
During the culture of the HUV membrane under static and dynamic conditions, the gas 
concentration of the culture environment was kept constant as 5% CO2 and 95% air. Gas 
tensions are important modulators of wound healing. Therefore, the potential of the HUV 
and bioreactor as an ideal experimental system with which to further our understanding 
of important biological events such as the interaction of various oral tissue cells, hypoxia 
and wound healing within and across a complex natural tissue matrix needs to be 
investigated. By using the modified bioreactor and dual circuit process flow, the O2 
tension will be modulated and the regenerative capacity of the HUV bioscaffold will be 
quantified by assessing proliferation, migration and remodeling activity of hGF.  
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Bacterial contamination of implanted GTR membranes is particularly important in any 
attempt to regenerate oral tissues, where appropriate biological events must take place in 
the presence of oral bacteria, generally in the form of complex biofilms. This is a key 
clinical problem in periodontal GTR, where the physical barriers used often become 
exposed directly to the oral environment during early wound healing after periodontal 
surgery.
462
 Clinical research indicates that early colonization of these materials does 
impair fibroblast migration into the healing periodontal wound.
463
 In vitro work has 
shown that both periodontal pathogens and streptococcal organisms readily colonize both 
collagen and synthetic GTR barriers and interfere with periodontal ligament cell 
attachment.
464
 In the light of these previous findings, a study for the quantification of 
bacterial invasion through the HUV bioscaffold should be conducted. 
In addition to the continued assessment of the processed HUV as a novel periodontal soft 
tissue repair scaffold, there is the potential of the HUV and bioreactor as an ideal 
experimental system with which to further our understanding of important biological 
events such as the interaction of various oral tissue cells, and host-bacterial interactions 
within and across a complex natural tissue matrix. By continuing development of the 
tissue bioscaffold and bioreactor based perfusion culture system, a number of 
opportunities can be explored to enhance the performance of the soft tissue matrix, such 
as: Surgical implantation to assess biocompatibility and regenerative capacity of the 
tissue bioscaffold, Micro-encapsulation technology can be used to deliver time-released 
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STANDARD CURVE USED FOR THE ASSESSMENT OF DOUBLESTRANDED 
(ds)-DNA QUANTITY (PICOGREEN ASSAY)  
 
The quantification of the double-stranded (ds)-DNA content within the tissue samples 
was done according to the manufacturer’s protocol. Briefly, DNA standards were 
prepared by serially diluting  DNA standard solution (100 g/mL in TE buffer) in 
deionized (DI) water as follows:  
 
Table A.1. Amounts and Concentrations Used for the  DNA Standard Curve  
Volume of 
standard used (L) 




0 1000 0 
1 999 0.1 
3 997 0.3 
10 990 1 
30 970 3 
 
 
Figure A-1 illustrates the standard curve obtained for  DNA standard. The standard 







Figure A.1.  DNA standard curve. The total concentration of DNA (g/mL) was plotted against 
relative fluorescence units. The fluorescence was linear from 0.1 to 3 g/mL with a correlation 
coefficient of 0.9955. 
 
 
 
 
 
